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Die effiziente Produktion rekombinanter Therapeutika in Säugerzellen und 
Verbesserung gentherapeutischer Verfahren sind bedeutende und expandierende Felder 
in der medizinischen und pharmazeutischen Forschung. Plasmid-DNA (pDNA)-basierte 
Vektorsysteme stellen aufgrund ihrer Stabilität, der kostengünstigen Produktion sowie 
ihres hervorragenden Sicherheitsprofils ein innovatives Gentransfer-System dar. Trotz 
dieser Vorteile ist der Einsatz von pDNA-Vektoren angesichts begrenzter 
Transgen-Expressionsraten gegenüber Virus-basierten Verfahren limitiert. Dies erfordert 
neue Strategien zur Optimierung von pDNA-basierten Genexpressionssystemen, wie 
beispielsweise durch die gezielte Nutzung transkriptionsregulierender Mechanismen der 
Zielzelle. CpG Dinukleotide in Transgenen haben sich diesbezüglich als entscheidende 
Expressions-modulierende Elemente erwiesen.  
Anhand der Reportergene codierend für das murine Makrophagen inflammatorische 
Protein 1 alpha (MIP-1α) und das humanisierte grün fluoreszierende Protein (GFP) 
konnte bereits in früheren Studien ein proportionaler Zusammenhang zwischen 
CpG Dinukleotiden im offenen Leserahmen und einem erhöhten Genexpressionslevel 
gezeigt werden. Dazu wurden die Nukleinsäure-Sequenzen der mip-1α und gfp Gene 
unter Verwendung alternativer Codons modifiziert. Ausgehend vom mip-1α Wildtyp 
wurde ein Codon-optimiertes Gen, sowie eine CpG-freie und eine CpG-maximierte 
Genvariante hergestellt. Weiterhin dienten das für humane Zellen Codon-optimierte gfp 
Gen und darauf basierend ein CpG-freies gfp Gen als Ausgangskonstrukte für 
Genexpressionsanalysen. Es konnte gezeigt werden, dass intragenische 
CpG Dinukleotide einen positiven Einfluss auf die Genexpression in Säugerzellen 
ausüben, während eine CpG-Depletion zu starken Expressionsverlusten führt. Während 
keine Hinweise auf veränderte CpG-basierte posttranskriptionelle Regulations-
mechanismen zu finden waren, konnte eine deutliche Korrelation zwischen 
intragenischen CpG Dinukleotiden und gesteigerter de novo synthetisierter mRNA 
hergestellt werden.  
In der vorliegenden Arbeit sollten die durch differenziellen intragenischen 
CpG-Gehalt hervorgerufenen Regulationsmechanismen von gfp und mip-1α aufgeklärt 
werden. Das relative Expressionsprofil der CpG-modifizierten gfp Transgene in CHO 
Flp-In Zellen konnte über den Zeitraum von mindestens einem Jahr durch 
antibiotischen Selektionsdruck konstant gehalten werden. Die Abwesenheit selektiver 
Bedingungen resultierte dagegen in sukzessiven Expressionseinbußen, welche sowohl 
auf Transgenverluste als auch DNA-Methylierung zurückzuführen waren. Während eine 
hohe intragenische CpG-Frequenz zu gesteigerten Methylierungsraten des Transgen-
kontrollierenden Promoters führte, hatte eine intragenische CpG-Depletion einen 
beschleunigten Transgenverlust zur Folge. Der Genexpressions-Rückgang nach 
Selektionsrestriktion korrelierte weiterhin bei allen gfp Varianten mit einer höheren 
Chromatin-Dichte. Interessanterweise ging auch die CpG-Depletion der in Flp-In CHO 
und HEK 293 stabil und unter Selektionsdruck integrierten gfp und mip-1α 
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Transgenvarianten mit einer Chromatin-Verdichtung einher. Darüber hinaus bewirkte 
der variable CpG-Gehalt in gfp eine veränderte in vitro-Positionierung von 
Nukleosomen. Die Detektion vermehrt aktiv transkribierender RNA Polymerasen II am 
Gen-Ende CpG-maximierter mip-1α Transgene in stabil transfizierten HEK 293 Flp-In 
Zellen ließ auf erhöhte Elongationsraten als Folge von CpG-Maximierung schließen. 
Expressionsanalysen von gfp Chimären konnten zeigen, dass sich nicht nur die 
CpG-Frequenz, sondern vielmehr die räumliche Nähe intragenischer CpG Dinukleotide 
zum Transkriptionsstart (TSS) positiv auf die Expressionseffizienz auswirken.  
Um die Effekte intragenischer CpG Dinukleotide auf die Transgenexpression in 
einem Gentherapie-relevanten Zellsystem zu testen, wurden murine, embryonale 
pluripotente Stammzellen der Linie P19 mittels lentiviraler Vektoren stabil mit den gfp 
CpG-Varianten unter verschiedenen Promotoren transduziert. Der Promotor des 
Cytomegalovirus (CMV) wies in diesem Expressionssystem eine erhöhte Disposition 
bezüglich gene silencing auf. Im Vergleich zum CMV Promotor führte der Promotor des 
humanen Elongationsfaktors 1 alpha (EF-1α) zu verzögerten, dennoch deutlichen, 
Expressionsverlusten. Im Gegensatz dazu verhinderte der bidirektionale, divergent 
transkribierte Promoter A2UCOE aufgrund seiner ubiquitären Chromatin-öffnenden 
Eigenschaften eine Transgen-Stilllegung komplett. In Bezug auf den intragenischen 
CpG-Gehalt konnte auch dieses Expressionssystem trotz hohem gene 
silencing-Potentials unter bestimmten Bedingungen von der Anwesenheit intragenischer 
CpG Dinukleotide profitieren. So wies das CpG-angereicherte gfp, exprimiert durch den 
EF-1α Promotor, auch in P19 Zellen eine deutlich erhöhte Expressionseffizienz auf. 
Weiterhin konnte die Gen-Stilllegung des CMV Promotor-kontrollierten gfp durch 
intragenische CpG Dinukleotide leicht verzögert werden. Die durch den 
A2UCOE Promotor vermittelte Transkription hingegen wurde durch intragenische 
CpG Dinukleotide in gfp nicht beeinflusst. Es wird vermutet, dass die 
Chromatin-öffnende Funktion des A2UCOE Elements eine Chromatin-Kompaktierung 
als Folge der CpG-Depletion verhindern kann. Mit dieser Eigenschaft scheint A2UCOE 
die Nachteile der CpG-Depletierung durch Chromatin Verdichtung aufheben zu können.  
Insgesamt konnten die anhand der Transgene gfp und mip-1α gewonnenen Daten 
zeigen, dass sich intragenische CpG Dinukleotide in TSS-Nähe positiv auf die 
Transkriptionseffizienz auswirken. Die durchgeführten Analysen deuten darauf hin dass 
dieser Effekt auf die Delokalisierung und Destabilisierung des +1 Nukleosoms durch 
TSS-proximale intragenische CpG Dinukleotide zurück geht, während eine intragenische 
CpG-Depletion eine Chromatin-Kondensation zur Folge hat. Diese Veränderungen der 
Chromatinstruktur werden als Ergebnis epigenetischer Regulationsmechanismen 
postuliert, die durch die An-, beziehungsweise Abwesenheit intragenischer 
CpG Dinukleotide hervorgerufen werden. Die genauen Mechanismen dieses Phänomens 
sind weiterhin nicht vollständig geklärt.  
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The improvement of gene therapy applications and efficient production of recombinant 
therapeutics in mammalian cells is a growing field of interest in medical and 
pharmaceutical research. Plasmid-DNA (pDNA)-based vector systems offer an 
innovative gene transfer strategy due to their high stability, cost efficient production and 
their excellent safety profile. Despite these advantages, the application of pDNA-vectors 
is limited compared to viral-vector-based gene transfer regarding transgene expression 
rates. This requires new strategies to optimize pDNA-based gene expression systems. 
The directed utilization of transcription regulating mechanisms in the target cell is a 
major strategy towards this aim. In this regard, CpG dinucleotides in transgenes have 
proven to serve as crucial expression-modulating elements.  
 Previous studies have demonstrated a strong correlation between the presence of 
CpG dinucleotides in transgenes and the level of gene expression by means of the 
reporter genes coding for the murine macrophage inflammatory protein 1 alpha (MIP-1α) 
and humanized green fluorescent protein (GFP). The DNA sequence of mip-1α and gfp 
was modified by using alternative codons. Based on the mip-1α wild type sequence, a 
codon optimized, CpG-depleted and CpG-enriched mip-1α gene variant were generated. 
Additionally, the CpG-rich gfp, optimized for human codon usage, and the 
CpG-depleted gfp, provided the basis for gene expression analyses. Decreased gene 
expression was observed as a result of intragenic CpG depletion, whereas the enrichment 
of intragenic CpG dinucleotides led to a dramatic increase of gene expression. No 
evidence for CpG-based posttranscriptional regulation mechanisms could be found. 
Instead, intragenic CpG dinucleotides clearly correlated with enhanced de novo 
synthesized mRNA.  
This study aimed to shed light on the CpG-induced mechanisms responsible for 
expression efficiency variations in gfp and mip-1α. The relative expression profile of 
CpG-modified gfp transgenes in CHO Flp-In cells could be maintained over at least a 
year under antibiotic selection pressure. Withdrawal of selective conditions resulted in 
gradual decrease in gfp expression which was shown to be a consequence of both 
transgene loss and DNA methylation. While a high intragenic CpG frequency promoted 
DNA methylation rates of the mediating promoter, intragenic CpG depletion led to 
accelerated transgene loss. Moreover, gene expression decline upon selection pressure 
withdrawal correlated with a higher chromatin density in both gfp variants. Notably, 
chromatin compaction also correlated with intragenic CpG depletion in gfp and mip-1α, 
stably expressed in Flp-In CHO and HEK 293 cells under selection pressure. 
CpG variations in gfp were furthermore shown to influence nucleosome positions 
in vitro. The detection of increased actively transcribing RNAPII at the gene end of 
CpG-maximized mip-1α transgenes in stably transfected HEK 293 Flp-In cells indicated 
enhanced elongation rates resulting from CpG enrichment. Expression analyses of gfp 
chimera revealed that not only the CpG frequency, but rather the proximity of intragenic 
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CpG dinucleotides to the transcription start site (TSS) is beneficial for transgene 
efficiency.  
To test the effects of intragenic CpG dinucleotides on transgene expression efficiency in 
a gene therapy-relevant cell system, murine embryonic pluripotent stem cells of the line 
P19 were stably transduced with lentiviral vectors (LV) containing the respective 
gfp variants under different promoters. The promoter of the cytomegalovirus (CMV) 
revealed a high disposition for gene silencing in this expression system. Compared to the 
CMV promoter, gfp transcription by the elongation factor 1 alpha (EF-1α) promoter 
resulted in delayed, yet significant transgene silencing in P19 cells. In contrast, the 
bidirectional, dual divergently transcribed A2UCOE promoter prevented transgene 
silencing via its chromatin opening abilities completely. With regard to CpG frequency, 
the LV-P19 expression system could also benefit from the presence of intragenic 
CpG dinucleotides under certain conditions, in spite its high gene silencing potential. 
EF-1α-promoter-controlled expression of the CpG-maximized gfp variant was clearly 
increased over the CpG-depleted gfp in P19 cells. CMV promoter-mediated 
gfp expression revealed slightly delayed gene silencing in CpG-rich compared to 
CpG-depleted gfp. In contrast, A2UCOE-mediated transcription was not affected by 
intragenic CpG dinucleotides. It is assumed that A2UCOE can overcome chromatin 
compaction arising from intragenic CpG depletion due to its chromatin opening 
property.  
The sum of data could show that TSS-adjacent intragenic CpG dinucleotides in gfp 
and mip-1α transgenes positively influence transcription efficiency. The results gained in 
this work imply that this effect results from delocalization and destabilization of the 
+1 nucleosome, whereas intragenic CpG depletion leads to a higher level of chromatin 
density. These chromatin changes are assumed to result from a complex epigenetic 
regulation network triggered by intragenic CpG changes. The exact mechanism of this 
phenomenon remains to be elucidated.  
 
Introduction  
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 Eukaryotic gene transcription 3.1
The regulation of gene transcription is fundamental for cellular differentiation, 
proliferation and the proper response to environmental changes. To achieve the high 
level of specialization of cells that have a common set of genetic information, gene 
transcription is subjected to multiple regulatory mechanisms. In prokaryotes, gene 
regulation allows a single cell to respond to environmental changes by switching genes 
on and off [1]. In multicellular eukaryotic systems, gene regulation not only serves to 
adjust to environmental changes. The biologically more important purpose of gene 
control is to provide the proliferation of many different cell types that compose a 
multicellular organism. Eukaryotic transcription is an immensely complicated process 
that is regulated by a large number of proteins (Figure 1) [2]. Sequence-specific binding 
factors/transcription factors interact with their DNA motifs in response to cellular 
signals [3]. They recruit transcriptional co-regulators to alter the local chromatin 
environment and facilitate assembly of the pre-initiation complex (PIC) [4], which is 
composed of the general transcription factors (GTFs) and Polymerase II (RNAPII) [5]. 
Among the three eukaryotic Polymerases, RNAPII, consisting of 12 subunits, is 
responsible for the transcription of protein coding genes [6]. GTFs, comprising TFIIA, 
TFIIB, TFIID, TFIIE, TFIIF and TFIIH, are essential for exact positioning of RNAPII at the 
promoter. Associated as the basal transcription machinery, RNAPII and GTFs form a 
preinitiation complex (PIC) at the core promoter, which is usually located upstream of 
the translated region [7]. Most core promoters contain a TATA box or equivalent motifs 
as an essential recognition feature for the basal transcription machinery [8]. TATA-boxes 
are present in the core promoter region and are typically 30–60 base pairs (bp) upstream 
of the transcription start site. In addition to these promoter motifs, the initiator (Inr) or 
downstream promoter element (DPE) interact with various components of the basal 
transcription machinery [9]. Another feature found at promoters of expressed genes in 
the yeast genome is the nucleosome-free region (NFR) [10]. What exactly creates an NFR 
is not fully understood, although some studies could correlate NFRs to poly-dA-dT tracts 
[11] or CpG islands [12]. Besides promoter regions, enhancers, also termed distal 
regulatory elements (DREs), contain binding sites for transcription factors. They can be 
located up to several thousand base pairs away from the actual initiation site [13]. 
Sequence-specific DNA binding transcription factors act as activators or repressors of 
transcription. They simultaneously recognize both promoter or enhancer sequences and 
other co-regulators through their DNA-binding domains and activation domains [4]. 
Whether a sequence-specific regulator activates or represses gene transcription depends 
on the genomic context and recruited co-regulators [2]. Co-regulators mainly comprise 
chromatin-modifying and/or chromatin-remodeling enzymes and the mediator complex 
[14]. The mediator complex facilitates the interaction between DNA-binding 
transcription factors, co-regulators and the basal transcription machinery [15]. 
Introduction  
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Figure 1 | Regulation of eukaryotic transcription (simplified). Assembly of the PIC, 
containing RNAPII (light grey) and GTFs (dark grey) is initiated by binding of TFIID to 
core promoter elements like TATA box, Initiator (Inr) or downstream promoter 
element (DPE) (purple). Transcriptional gene regulation involves: the binding of 
sequence specific binding factors (light green) to distal regulatory elements (DREs) 
and proximal promoter regions; interactions of DNA-binding factors with co-
regulators like mediator (yellow), histone modifying complexes (green), chromatin 
remodelers (orange) and the basal transcription machinery (grey). The C-terminal 
domain (CTD) (red wavy line) is unphosphorylated in the PIC and becomes multiply 
phosphorylated upon initiation. As RNAPII traverses a transcription unit, the 
phosphorylation pattern changes resulting in the recruitment of different proteins. 
The concerted function of all these factors is to express a subset of genes as dictated 
by a complex interplay of environmental signals. 
The C-terminal domain (CTD) of the largest subunit of the eukaryotic RNAPII contains 
several YSPTSPS heptad repeats (52 in mammals) that are unphosphorylated in the PIC  
of RNAPII and become multiply phosphorylated upon initiation [16]. As RNAPII 
traverses a transcription unit, the phosphorylation pattern changes resulting in the 
recruitment of different proteins to the CTD [17]. Phosphorylation has predominantly 
been found at serine 2 and serine 5 of the heptad repeats. Phosphorylation of the serine 5 
residue occurs during transcription initiation and has been connected to multiple 
processes of transcription such as promoter clearance for transition from initiation to 
early elongation and 5′-end capping of pre-mRNA [18]. Modification of serine 2 is found 
TATA Inr DPE
IID
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when the polymerase is associated with the coding region and has been implicated in 
productive elongation and the 3′-end processing of the transcript [19].  
Several regulatory proteins specifically recognize the respective phosphorylation 
pattern of the CTD. Thereby, the CTD of RNAPII coordinates events during the 
transcription cycle by recruiting co-regulators involved in histone modifications and/or 
remodeling, transcription elongation, termination and mRNA processing [2]. 
 Chromatin  3.2
Eukaryotic DNA is up to a thousand times longer than the cell’s length [20]. Therefore, 
an organized packaging system is needed to fit the DNA into the nucleus. The 
nucleoprotein complex that meets this requirement is called chromatin. The term was 
first used by Walther Flemming, who discovered a visible cell substance with staining 
characteristics and therefore named it chromatin, which means “stainable material” [21].  
Different states of chromatin, called euchromatin and heterochromatin, are found in 
the nucleus. They correlate with transcriptional active or repressed genes. Euchromatin 
undergoes a process of condensation and decondensation during cell cycle. It constitutes 
the majority of the chromosomal material and contains genes that are actively 
expressed. Heterochromatin remains highly condensed during the cell cycle. It is mostly 
found at the centromers and telomers of chromosomes as well as along the entire 
inactive X chromosome in female mammals [22].  
 The nucleosome 3.2.1
Nucleosomes are the primary structural units of chromatin, composed of DNA and 
histones. Histones are highly conserved, basic proteins of 11 to 21 kilo Dalton (kDa) 
(Table 1). In 1997, the structure of a nucleosome core particle could be resolved by X-ray 
diffraction at a resolution of 2.8 Å (Figure 2) [23]. It shows a nucleoprotein complex of 
approximately 147 bp of genomic DNA wrapped in a left handed superhelix 1.7 times 
around a histone octamere which has a diameter of 11 nm in length and 5.5 nm in height. 
Table 1 | Molecular weight and size of histones. Values given are derived 
from bovine histones. Modified from [24]. 
Histone protein Molecular weight [kDa] 
Number of 
 amino acids 
H1 21,130 223 
H2A 13, 960 129 
H2B 13,774 125 
H3 15,273 135 
H4 11,236 102 
Introduction  
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A histone octamere contains two copies each of histones H2A, H2B, H3 and H4. All four 
histone proteins have a similar structural motif in common. The trihelical histone fold 
core mediates both binding between histones itself and between histones and DNA. 
Each histone has polypeptide extensions with NH2- and/or COOH-terminal ends that 
stick out from the globular regions. These tails are targets for posttranslational 
modifications like acetylation and methylation [25]. Different from the rest of the 
histones, histone H1 is involved in the chromatin packing into a higher-order structure 
[20]. 
 
 
 
Figure 2 | Structure of the nucleosome core 
particle. The model shows the DNA double helix 
(brown and torquiouse) wound around the central 
histone octamere, consisting of two copies each 
of histones H2A, H2B, H3 and H4. Hydrogen 
bonds and electrostatic interactions between 
histones and DNA keep the nucleosome in place 
[23]. 
 Chromatin organization 3.2.2
Nucleosomes are connected by nucleosome-free linker DNA to form a 10-nm fiber, also 
called the “beads-on-a-string array” [26][27]. The length of linker DNA varies among 
species, ranging from about 20 to 60bp. The linker region and parts of the nucleosomal 
DNA are associated with the linker histone H1, which binds to the nucleosome and 
causes the assembly of nucleosomes into a higher-order structure, the 30-nm filament 
[25][20]. While the X-ray crystal structure of the nucleosome core particle has early been 
resolved in atomic detail [23], the structure of the 30-nm chromatin fiber has been an 
issue of debate. In 1976, Finch and Klug postulated the “solenoidal model for 
superstructure in chromatin”, which would direct the linker DNA between two 
nucleosomes into a strong bend [28]. For another model of organization, the so called 
Introduction  
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zig-zag structure, it was assumed that the linker DNA is straight and crosses the center 
of the 30-nm fiber [29]. X-ray analysis of a tetra nucleosome seems to support the 
zig-zag structure, which falls into the category of the 'two-start helix' type [30]. By 
contrast, electron microscope measurements provide evidence for the solenoid model 
characterized by interdigitated nucleosomes [31]. Both models agree on the function of 
the linker histone to determine the topology and degree of chromatin compaction [32]. 
Very recent analyses indicate that the 30-nm fiber involves both zigzag and bent linker 
motifs, depending on physiological conditions [33]. The 30-nm chromatin fiber results in 
an approximately 50-fold compaction of DNA. To obtain a higher level of organization, a 
hierarchical folding of chromatin structure, schematically illustrated in Figure 3, is 
needed [22]. A series of loops of 30-nm fibers are anchored at their base to the chromatin 
scaffold to form the 300-nm fiber [34]. The chromatin scaffold consists of non-histone 
proteins and has the shape of a metaphase chromosome. On average, each loop 
encompasses 20.000 to 500.000bp of DNA and is about 300nm in length. Tight helical 
coiling of the 300nm fiber produces the scaffold-associated chromatin structure. This 
helix is again packed and folded to generate an individual 700nm wide chromatid, two of 
which compose a metaphase chromosome [22] (Figure 3).  
 
 
 
 
Figure 3 | Hierarchical folding of chromatin. (A) Beads-on-a-string array. 
Alternating nucleosomes are depicted with blue and green surfaces; (B) The 
30-nm fiber twists further and forms a more compact fiber (C) that is 
arranged in loops (blue), with some portions attached to a protein scaffold 
(red) (D); (F) metaphase chromosome. Modified from [35]. 
 
 
 
A 
B C 
D 
E 
Introduction  
Page | 10  
 
The mechanism of higher order chromatin formation, ultimately resulting in metaphase 
chromosome formation, is still poorly understood. Multiple chromatin-associated 
proteins (CAPs) have been suggested to play an important role in the formation and 
dissociation of the chromatin structure beyond the 30-nm fiber. H1 is considered to be 
an important CAP in the organization of higher chromatin structure by stabilizing the 
folded state as was revealed by electron microscopy [36]. An important process for 
chromosome organization is the interaction of core histone domain tails which are also 
targets of multiple modifications in the course of gene transcription [37].  
 Transcriptional control by chromatin 3.3
Chromatin generally limits the accessibility of specific DNA sequences and inhibits the 
initiation and progression of the polymerase during transcription. There are basically 
three different ways by which the chromatin structure can be altered: i)By chromatin 
remodeling, ii)histone modification and iii) the replacement of core histones by histone 
variants. Together with DNA methylation and RNA binding, these regulation 
mechanisms are summarized as epigenetic control [38]. 
 Histone modifications 3.3.1
To date, more than a hundred of histone modifications have been found. Several recent 
reviews cover this complex topic [39][40][41]. In the following sections, only a selection 
of modifications controlling gene activity is discussed. Among the many types of histone 
modifications that have been detected so far, acetylation, methylation and 
phosphorylation are the most frequently detected and best understood (Table 2). Over 
60 different histone residues have been identified to be a target of modification, and in 
the case of methylation, multiple modifications (mono-, di- and trimethyl) can occur at 
one lysine or arginine [42][43].  
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Table 2 | Overview of the most important types of histone modifications in mammals. Modified 
amino acids include Lysine (K), Arginine (R), Serine (S), Threonine and Proline (P). Modified from  
[44]. 
 
 
Depending on type and position of modification, opposed effects on transcription rate 
have been observed. The acetylation of histones generally activates a gene cumulatively, 
whereas methylation can have opposing effects (Table 2). Modifications that have been 
connected with transcription activation have been described as euchromatin 
modifications. Those that have been mapped to inactive genes are referred to as 
heterochromatin modification [45].  
Genome-wide studies have revealed that individual histone modifications can be 
mapped to specific states of gene activity [46] (Figure 4). For example, the modifications 
H3K4me2/3 (histone H3 lysine4 di- and trimethylation) are mainly found in actively 
transcribing promoters, and H3K36me3 is frequently found in the body of actively 
transcribed genes, increasing towards the 3’ end. By contrast, modifications like 
H3K27me3 and H4K20me3 are mostly mapped to regions where transcription is 
repressed [39]. Some modifications, such as H3K27me3 and H3K4me3 are however 
coincident with both activation and repression of gene transcription, respectively 
(Figure 4). 
Modifications Residues Modified Modification Position Impact on Transcription 
Acetylation  K-ac 
H3 (9,14,18,56), H4 (5,8,13,16), H2A, 
H2B  
Activation 
Methylation (lys)  K-me1 K-me2 K-me3 
H3 (4,36,79) Activation 
H3 (9,27), H4 (20) Repression 
Methylation 
(arg) 
R-me1 R-me2a R-
me2s 
H3 (17,23), H4 (3) Activation 
Phosphorylation  S-ph T-ph H3 (3,10,28), H2A, H2B Activation 
Ubiquitylation K-ub 
H2B (120)  Activation 
H2A (119) Repression 
Sumoylation K-su H2B (6/7), H2A (126) Repression 
Isomerization P-cis > P-trans H3 (30-38) Activation/ Repression 
Introduction  
Page | 12  
 
 
Figure 4 | Distribution of histone modifications on active and inactive genes. Modification patterns differ 
on actively transcribed and silenced genes, which is displayed as a schematic view of modification 
distribution over the gene. Promoters of actively transcribed genes carry high levels of active modifications 
such as acetylations and methylation of H3K4. At the transcriptional start site there is a 
nucleosome-free region (NFR) within the promoter. Inactive genes have a fairly even distribution of 
silencing modifications, such as H3K9 methylation and H4K20 methylation, whereas H3K27 methylation is 
enriched in the promoter. Modified from [39]. 
Strahl and Allis postulated the hypothesis of a histone code, proposing that the 
combination of histone modifications at a certain genomic locus determines the activity 
state of the underlying gene [47]. This hypothesis of a histone code is heavily discussed 
within epigenetic research, arguing that gene regulation by histone modifications might 
rather reflect a cumulative more than a combinatorial effect [48]. Nevertheless, the 
frequently made observation of distinct histone patterns demonstrates that histone 
modifications can indeed serve as indicator for gene activity or inactivity. In what 
respect these histone distributions are a matter of cause or consequence of gene activity 
is however not fully understood [39].  
Histone modification is carried out by a variety of enzymes, categorized as 
acetyltransferases, methyltransferases, kinases etc. A detailed list of histone modifying 
enzymes is reviewed by Kouzarides [44]. The co-presence of both modifying and de-
modifying enzymes indicates that histone modification is a highly dynamic process.  
Active Gene
Inctive Gene
NFR
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There are two major functions of histone modifications. First of all, histone 
modifications result in the weakening of inter- and intranucleosomal as well as 
histone-DNA interactions, thereby relaxing the chromatin structure. A simple 
consideration that led to this assumption is the fact that, apart from methylation, 
histone modifications all result in a net charge change of nucleosomes [39]. The 
disruption of chromatin contacts allows transcription factors to bind to their targets and 
is therefore fundamental for transcription. The second purpose of histone modification 
is the direct recruitment of regulatory proteins or DNA-methyltransferases (DNMTs) to 
their cognate binding sites [49]. An example for such co-regulators is the SET domain-
containing histone methyltransferase enzyme SUV39H1, which is responsible for 
trimethylation of H3K9 and heterochromatinization of pericentromeric satellite repeats. 
These proteins are also required to recruit de novo methyltransferases to methylate CpG 
dinucleotides in the satellite sequence [50]. In addition to transcription factors and DNA 
modifying enzymes, histone modification patterns interact with remodeler complexes 
[43].  
 Chromatin remodeling 3.3.2
The dynamic property of DNA is maintained by chromatin remodeling complexes. These 
multi-protein complexes are essential for many chromatin functions such as the proper 
spacing of nucleosomes during nucleosome assembly, DNA repair or the binding of 
transcription factors to specific genes in the course of transcription regulation [51]. A 
broad range of remodeler complexes has been identified. All of them contain an ATPase 
domain which belongs to the superfamily II (SFII). On the basis of sequence similarities 
of the ATPases, remodeller complexes can be grouped into a number of subfamilies 
[52][53]. Most of these subfamilies have been designated to the archetypal member, such 
as S.cerevisiae Snf2p (Snf2 subfamily), Drosophila melanogaster Iswi (Iswi subfamily), or 
Mus muculus Chd1 (Chd subfamily). Several of them, e.g. members of the Iswi subfamily, 
have been reported to possess DNA-translocation activity [54]. Different remodelers 
affect the structure of the nucleosome array in a particular way and thereby influence a 
widespread number of nuclear processes, reviewed in [52]. For instance, the members of 
Iswi, namely the NURF (nucleosome remodeling factor), CHRAC (chromatin 
accessibility factor) and ACF (ATP-utilizing chromatin-assembly and remodeling factor) 
predominantly position nucleosomes in a manner to repress transcription [55]. By 
contrast, RSC (remodels the structure of chromatin), a member of the Swi/Snf family, 
mediates pathways that both activate and repress transcription [56]. Different than the 
variety of remodelers with regard to substrate specificity and chromatin product, the 
mechanism by which nucleosomes are rearranged has been suggested to be uniform. 
According to the ‘loop recapture model’, DNA translocation against a histone octamere 
is achieved by the successive detachment of DNA, starting from the edge of the 
nucleosome, its bending and recapturing by the octamere to form a loop that is carried 
along the DNA strand [57]. 
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 Sequence dependent nucleosome positioning 3.3.3
It is now well established that the DNA sequence itself determines the strength of 
DNA-histone interactions and the bending flexibility of the DNA helix around a histone 
octamere [58][59]. Poly (A) and poly (T) regions result in conformationally rigid 
molecules and therefore require high energy to incorporate into nucleosomes. By 
contrast, dinucleotides form nucleosomes of high stability: AA, TT and TA dinucleotides 
are favored approximately every 10bp where both DNA strands face towards the 
nucleosome core. GC dinucleotides are favored approximately every 10bp where both 
phosphodiester backbones face outward (Figure 5). A study of Gupta et al. has identified 
a 3bp periodicity of CG and GC dinucleotides to be a highly nucleosome favored 
sequence [60]. 
 
 
Figure 5 | Three dimensional structure of one-half of a symmetric 
nucleosome. Bends around the nucleosome core are favored by the 
dinucleotides AA/TT/TA that oscillate approximately 10bp periodically in 
phase with each other and out of phase with GC dinucleotides recurring 
every approximately 10bp as indicated [59].  
 
The sequence preference calculation is based on a thermodynamic model that evaluates 
the free energy for any nucleosome constellation [59]. This includes the calculation of 
sterically allowed nucleosome organizations and competition between positions at each 
dinucleotide. A genome-wide analysis of nucleosome positioning demonstrated that 
approximately 50% of the in vivo nucleosome organization is solely determined by 
sequence preferences of nucleosome occupation [61]. By using high-density tiling arrays 
over the yeast genome, it was shown that a nucleosome-free region (NFR) was a 
common feature of promoters [10]. The so-called “−1” and “+1” nucleosomes are located 
in canonical regions upstream and immediately downstream of the NFR, respectively. 
These well-positioned nucleosomes encompassing the NFR at promoters have regulatory 
functions of transcriptional regulation (see chapter 3.1) [62].  
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 Cytosine Guanine Dinucleotides  3.4
Nucleosome positioning is influenced by short periodic repeats of cytosines followed by 
a guanine [60]. These so called CpG dinucleotides are significantly underrepresented 
throughout the vertebrate genome than would be calculated from base composition.   
[63][64][65]. Since cytosines within CpGs are the exclusive targets for methylation in 
vertebrates, it was anticipated that this deficiency was related to DNA methylation [66]. 
The selective pressure resulting in this CpG loss was provided by the inherent mutability 
of methylated cytosine. The deamination of cytosine results in uracil, which is easily 
recognized and removed by uracil glycosylases. By contrast, the deamination of methyl 
cytosine gives rise to thymine, which is not recognized as foreign and therefore leads to 
a transition mutation in the subsequent replication. As a result, methylated CpG 
dinucleotides in the germ line tend to be lost over time [67]. Organisms with high levels 
of DNA methylation therefore tend to exhibit the most pronounced CpG deficiency [65]. 
 CpG methylation  3.4.1
DNA methylation patterns among eukaryotes are not uniform. The most frequent 
pattern found in invertebrate animals is the so-called ‘mosaic methylation’. It is 
characterized by moderate levels of methyl-CpG dinucleotides accumulated in domains 
of methylated DNA, interspersed with unmethylated domains. Vertebrates, on the other 
hand, exhibit high levels of methylated CpG dinucleotides distributed over the entire 
genome, except for small methylation free regions at transcriptionally active regions. 
This pattern is referred to as the ‘global methylation’ [68]. The transition from the 
ancestral mosaic methylation to the vertebrate global methylation is believed to have 
evolved in the evolution of CpG DNA immunity. The genomes of most bacteria and 
DNA viruses are rich in unmethylated CpG dinucleotides. These CpG motifs of several 
microbial parasites are detected by pattern recognition receptors, such as the Toll-like 
receptor 9 (TLR9), during the innate immune response in some vertebrates [69]. Since 
methylated CpGs have no potential to activate this defense, the genome of the host 
vertebrates prevents an auto immune response. The CpG-poor, globally methylated 
vertebrate genome is therefore believed to be a prerequisite of the CpG immunity [68]. 
The DNA methylation patterns in mammalian cells are usually well regulated and tissue-
specific [70][71]. DNA methylation patterns of specific cell types are established during 
mammalian development and maintained in adult somatic cells [72]. In mammalian 
germ cells and early embryos, dramatic reprogramming with complete removal of 
methylation occurs, followed by renewed de novo methylation [73]. Not only global 
methylation changes, but also gene-specific de novo methylation and demethylation 
have been observed, for example during differentiation of hematopoietic progenitors 
[74]. DNA methylation in mammalian cells is mostly correlated with gene silencing, 
which is virtually always the case if this concerns promoter elements [75][76]. However, 
DNA methylation of gene bodies is also found to be positively correlated with 
transcription [77][78][79]. 
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The majority of methylated DNA in differentiated cells is however harbored by 
non-coding transposable elements such as SINEs (short interspersed nuclear elements), 
LINEs (long interspersed nuclear elements) and endogenous retroviruses. These 
elements encompass approximately 42% of the human genome [80][81]. 
 
Methylation occurs at the 5-position of the cytosine residue within CpG dinucleotides, 
resulting in 5-methylcytosine (m5C). The reaction is catalyzed by DNA 
methyltransferases (DNMTs), which catalyze the transfer of a methyl group from 
S-adenosyl-L-methionine to cytosine [82]. There are three enzymatically active DNMTs, 
which can be divided into de novo and maintenance methyltransferases. De novo 
methyltransferases act after the replication in unmethylated DNA. Maintenance 
methyltransferases catalyze the addition of methyl groups to hemi-methylated DNA 
during replication [82]. DNMT1 is the major maintenance methyltransferase [83]. 
DNMT3A and DNMT3B are de novo methyltransferases acting on unmethylated DNA. 
They are responsible for establishing methylation patterns during early development 
and each of them has distinct functions [84]. DNMT3L is a protein that is homologous to 
DNMT3A and DNMT3B but contains no catalytic activity. Instead, DNMT3L assists the 
methylation during gametogenesis by recruiting de novo methyltransferases [85]. DNA 
demethylation can be accomplished either passively, by leaving the new DNA strand 
unmethylated after replication, or actively. Some studies support the existence of active 
demethylation in zygotes [86] and in somatic cells [87]. So far, the exact mechanism is 
still not fully understood. 
 Unmethylated CpG dinucleotides 3.4.2
CpG dinucleotides are largely depleted throughout the mammalian genome as a 
consequence of their high susceptibility to mutation [66]. The result is that CpGs are 
relatively rare unless there is selective pressure to keep them or a region is not 
methylated due to active regulation of gene expression. Those genomic loci are mostly 
promoter regions of housekeeping genes that comprise at least half of the genes in the 
human genome [76]. 
It has been suggested that the unmethylated state of CpG dinucleotides is also 
dependent on germ line and early embryonic transcription. As a result of this lack of 
methylation, CpG dinucleotides in these regions are less suppressed and consequently 
appear relatively CpG-rich compared with the rest of the genome [88]. These stretches of 
mostly non-methylated CpGs are called CpG islands. CpG islands, defined by Bird in 
1986, are on average 100obp of length, have a C+G content of 0.5 or higher and an 
observed to expected CpG dinucleotide ratio of 0.6 or higher within a range of 200bp or 
greater [89][90]. CpG Islands are mostly found within the promoter and the first exon of 
several genes, particularly housekeeping genes [67][91]. In addition to housekeeping 
promoters, the average of protein coding genes in the human genome display a 
significant excess of CpG dinucleotides in exons, most pronounced in the first exon, 
compared to introns [67][92][93][94]. 
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 Gene control mechanisms directed by CpG dinucleotides 3.4.3
The high frequency of CpG dinucleotides in promoters and gene bodies of constitutively 
expressed genes versus the low frequency of CpG dinucleotides in mostly non-functional 
DNA already points to the outstanding role of this element as a transcriptional regulator. 
Despite more than 25 years of intensive study on CpG islands/regulatory CpG motifs 
since their discovery [89], the exact mechanisms by which CpG dinucleotides affect gene 
transcription are still poorly understood.  
Trans acting proteins have been found that interact with unmethylated CpG 
dinucleotides leading to a unique chromatin architecture [95]. The transcription factor 
Sp1, for instance, has been demonstrated to bind to unmethylated CpG Islands to protect 
them from de novo methylation, which ensures active gene transcription [96]. In 
addition to Sp1, the CRE binding factor (CREB) [97] and CCCTC binding factor (CTCF) 
[98] contain CpG in their binding recognition site and DNA recognition is impaired 
upon CpG methylation. 
More than 15 years ago, another important factor binding to unmethylated CpG 
dinucleotides was found in tobacco: the nuclear CpG-binding protein 1 (CGBP-1) binds 
with high affinity to unmethylated CpG dinucleotides [99]. A human CpG binding 
protein (hCGBP) was isolated a few years later, revealing specific binding for 
unmethylated CpG dinucleotides and thereby functioning as a transcriptional activator 
[100]. Subsequently, this protein was renamed as CXXC finger protein 1 (CFP1) [101]. CFP1 
has frequently been localized in nuclear regions that are associated with euchromatin, 
which underlines its exclusive function as a transcriptional activator [102]. 
The key feature of CFP1 is a cysteinrich CXXC DNA-binding domain [100]. This zinc-
finger like domain is highly conserved and frequently found in proteins involved in 
epigenetic regulation, such as the DNA methyltransferase 1 (Dnmt1) [103], methyl-CpG 
binding proteins MBD [104] and histone H3-Lys4 methyltransferase [105]. CFP1 was 
shown to associate with a histone H3K4 methyltransferase complex (SET1 complex) 
catalyzing the addition of the tri-methyl modification (H3K4me3) [106]. H3K4me3 
coincides with promoters and 5’ end of actively transcribed genes [107] (see also chapter 
3.3.1). Histone lysine methylation marks are recognized by specific effector proteins 
containing plant homeodomain (PHD) finger domains or chromatin organization 
modifier (chromo) domains. PHD finger proteins can activate gene transcription, such 
as via TFIID [108] and the nucleosome remodeling factor (NURF) [109]. Another 
transcription factor binding to unmethylated CpG dinucleotides via the zink finger 
CXXC domain is the H3K36-specific lysine demethylase enzyme KDM2A. Binding of 
KDM2A to CpG results in removal of H3K36 methylation, thereby creating a “CpG island 
chromatin” that is depleted of this repressive modification [110].  
The binding of unmethylated CpG dinucleotides by CpG-specific transcription 
factors, which are able to affect histone modifying activities, suggests that CpG 
dinucleotides may use chromatin associated processes to provide a transcriptionally 
active surface [95]. In addition to chromatin mediating abilities, early studies of CpG 
island chromatin revealed a distinct depletion of Histone H1 at CpG islands [111]. Histone 
H1 represses transcription [112] due to stabilization of chromatin structure [113]. 
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Methylated CpG dinucleotides of regulatory elements have also been found to direct 
numerous gene control processes. For example, CpGs involved in tumori-genesis [114] or 
genomic imprinting [115] become methylated during cellular differentiation. DNA 
methylation has been shown to block the recruitment of zink finger CXXC proteins 
which then creates a repressive chromatin environment [107][110]. 
 Additionally, methylated CpG dinucleotides provide binding sites for methyl CpG-
binding domain proteins (MBDs) that interact with further co-regulators like histone 
deacetylase (HDAC) eventually leading to inhibition of gene expression [116]. A 
prominent mediator between DNA and histone modification is the DNMT3A/B homolog 
DNMT3L. DNMT3L binds to histone H3, and thereby recruits de novo 
methyltransferases to DNA. Once H3K4 becomes methylated, the interaction between 
DNMT3L and the nucleosome is inhibited [117]. Histone methyltransferases responsible 
for trimethylation of H3K9 are simultaneously required for the recruitment of DNMT3A 
and DNMT3B in order to methylate CpG dinucleotides, eventually leading to 
heterochromatinization at satellite sequences [50]. This process of 
heterochromatinization is initiated by a Dicer-mediated mechanism that recognizes 
RNA duplexes found at satellite sequences. The resulting RNA-induced silencing 
complex (RISC) is then specifically targeted back to pericentromeric regions where it 
probably recruits enzymes involved in this heterochromatin pathway [118][119][120]. 
Apparently, the interactions between histone and DNA modifying events can work in 
both directions: CpG methylation provides the template for some histone modifications, 
and histone modifications can recruit DNMTs. It seems that histone modifications 
provide more labile transcriptional repression, whereas DNA methylation is a rather 
stable epigenetic mark that is not easily reversed [49]. 
 
The mechanisms mentioned above are just a small insight into the many pathways that 
are directed by unmethylated or methylated CpG dinucleotides, respectively. Their 
extensive implications in epigenetic mechanisms underpin their role as a key player in 
transcriptional regulation. Despite recent advances in the understanding of regulatory 
CpG elements, there are still many gaps in the knowledge of this field that need to be 
filled to better understand cellular responses to the environment. Further to that, the 
understanding of CpG-mediated transcriptional control would be useful in the design of 
optimized transgene expression systems. 
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 Transgene expression  3.5
The design of optimized transgene systems is crucial for gene therapy applications and 
the production of recombinant proteins. Prokaryotic and simple eukaryotic expression 
systems are inexpensive, fast growing and easy to handle. Nevertheless, these systems 
lack a suitable native glycosylation machinery and may not fold and secrete the 
recombinant proteins correctly [121][122]. Due to these limitations, mammalian cell 
culture has become the standard system for recombinant protein production. 
Accordingly, about 60–70% of all recombinant pharmaceuticals are produced in 
mammalian cells, particularly CHO and HEK 293 cells [123]. The growing demand for 
therapeutic proteins requires the establishment of highly effective and sustainable 
expression systems. Besides optimization of the translational or secretory capacity of 
host cells, the maximization of transgene expression levels is a major attempt to increase 
protein yields [124]. The first step of successful transgene expression in the target cell is 
the choice of the appropriate gene delivery system. There are currently two major 
delivery categories used for transgene expression: plasmid-based and viral vector-based 
[125] (Figure 6).  
 
 
 
 
Figure 6 I Vectors used in gene therapy trials. Viral vectors, in particular 
retro- and adenoviruses, are the most frequently used vehicles for gene 
transfer to human cells. The development of efficient expression systems 
has made plasmid-based transgene delivery to the third most frequently 
used vector system in gene therapy trials [125]. 
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 Viral vector-based transgene expression 3.5.1
 
Viral vectors are mostly genetically modified, replication deficient viruses. They are able 
to transduce cells with high delivery efficiency and can be used in a variety of cells [125]. 
While DNA-based viral vectors, such as adeno and adeno-associated viruses (AAV), 
usually persist as episomal DNA in the host cell [126], retroviruses have the ability to 
confer long-term transgene expression through gene integration [127]. 
3.5.1.1 Retroviral vectors 
Retroviral vectors are generated by exchanging replication elements by the gene of 
interest. Necessary cis-acting RNA regions, primarily the long terminal repeat (LTR), 
which is necessary for packaging, reverse transcription, integration and transcription 
regulation, are retained. All viral genes are usually deleted from the viral vector. The 
production of attenuated retroviral vectors takes place in packaging cells that provide all 
essential viral proteins in trans. Transgenes are delivered into the cell by receptor 
mediated fusion of viral and host cell lipid membrane. Upon entrance of the viral vector 
into the cell, reverse transcription is initiated. The viral genome is converted to a 
double-stranded DNA provirus, which is then inserted into the host genome [127]. 
One subclass of retroviruses often used in gene therapy trials comprises lentiviral 
vectors. In addition to the three essential gag, pol and env gene products, lentiviruses 
contain accessory viral proteins that regulate viral gene expression and infectivity [128]. 
These viral proteins interact with the nuclear import machinery to mediate the active 
transport of the viral preintegration complex through the nucleopore. This ability 
enables lentiviruses to transduce non-dividing cells [129]. 
Lentiviruses preferably integrate into or in the proximity of active transcription units 
[130]. Self-inactivating retroviral vectors (SIN LVs) have a deleted U3 region of the 3’LTR 
containing the viral enhancer sequence. This ability provides gene transfer with higher 
safety due to the reduced risk of enhancer-mediated mutagenesis [131]. Transgene 
expression in LVs has been shown to undergo epigenetic modifications, eventually 
leading to gene silencing [132][133][134].  
3.5.1.2 Ubiquitously acting chromatin opening elements (UCOEs) 
An attractive approach to overcome transgene silencing in LVs is the introduction of 
ubiquitously acting chromatin opening elements (UCOEs). UCOEs are regions 
containing CpG islands extending over dual divergently transcribed promoters derived 
from housekeeping gene loci [135][136]. UCOEs have been reported to provide stable 
transgene expression in cell culture systems even when integrated into heterochromatin 
regions [135]. This feature confers considerable utility for gene therapy and recombinant 
therapeutic applications. 
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 Plasmid-based transgene expression 3.5.2
Alternative to virus-based delivery systems, which still bear several safety risks, plasmid-
based gene delivery has become a common technique in gene therapy, DNA vaccination 
and the production of recombinant proteins in mammalian cells [137]. Plasmid DNA can 
be delivered to cells either physically or by synthetic particles. These particles typically 
consist of DNA complexed with cationic lipids, peptides or polymers capable of efficient 
gene transfer into the target cell. The easiest physical method of transgene delivery is by 
needle injection into the target tissue, i.e. muscle cells [138], skin [139], liver [140] or 
tumor [141]. Needle injection is the major application of DNA vaccination [142]. Other 
physical methods include electroporation [143], ballistic DNA administration [144] or 
sonoporation [145][146], just to name the most commonly used physical techniques. For 
review, see Kamimura et al [147]. 
Among the synthetic compounds, liposomes, particularly those composed of cationic 
lipids, have been reported to be most effective for gene delivery [148]. Liposomes are 
particles consisting of lipid bilayers encompassing an aqueous compartment. They are 
formed spontaneously when lipids are hydrated in an aqueous solution [147]. 
Alternative to liposomes, numerous polymer-based compounds such as 
polyethylenimine (PEI) [149], polyamidoamine [150], polyallylamine [151] and chitosan 
[152] are being widely employed today. These cationic polymers condense DNA into 
positively charged particles and prevent DNA from degradation. The cellular uptake of 
these complexes occurs via endocytosis [147].  
 
Besides simplicity of delivery, the advantages of plasmid-based transgene expression are 
low toxicity and sustainability. The main disadvantage of plasmid-based techniques 
compared to viral-based methods is the low gene delivery efficiency. Large efforts have 
been made to modify the carrier or delivery vehicle to achieve higher transfection rates 
[137]. High transfection rates are however useless if transgene expression is ineffective. 
Once inside the cell, plasmid DNA is subjected to the cells regulation mechanisms that 
can directly be influenced by sequence elements of the plasmid DNA [137].  
Plasmid-based vectors have a large capacity for transgene DNA. Rational plasmid 
design aims for the manipulation of a variety of regulatory factors that impact on gene 
transfer and gene expression. A plasmid accommodates the expression cassette (EC), 
which contains the gene(s) of interest and any regulatory sequences required for 
expression in mammalian cells, such as the promoter and the poly A site. The rest of the 
plasmid, the bacterial backbone (BB), usually contains an antibiotic resistance gene and 
an origin of replication required for the production of the plasmid DNA in bacteria [153]. 
Numerous efforts have been made to establish systems providing efficient plasmid-based 
transgene expression. One approach to improve transgene expression is to generate 
minicircles. In minicircles, the BB is removed by site-specific recognition sequences, 
which results in the generation of two smaller supercoiled minicircles. The minicircle 
harboring the EC is then separated from the other circle containing unwanted BB 
elements [154] such as antibiotic resistant genes or elements provoking DNA 
methylation and heterochromatin-associated histone modifications [137]. Another 
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strategy to avoid transgene silencing is the inclusion of a scaffold matrix attachment 
region (S/MAR). S/MARs are AT-rich sequences derived from eukaryotic DNA where the 
nuclear matrix attaches. They have been shown to contain DNA-unwinding elements 
and binding sites for transcription factors and topoisomerase II. Since S/MARs harbor 
mammalian origins of replication, they can promote sustainable episomal replication 
and maintenance in mammalian cells [155]. Another crucial factor for successful 
transgene expression is the careful choice of an appropriate promoter. Dependent on the 
type of application and target cell or tissue, different promoters should be selected. 
Endogenous housekeeping promoters express at low but constitutive rates. Due to this 
ability, they are recently preferred over viral promoters that provide high but often 
unstable transgene expression due to gene silencing [137]. Furthermore, a tissue-specific 
promoter has the potential of improved specificity and safety [156][157].  
 
The adaptation of the codon usage has proven to be extremely effective in promoting 
transgene expression [158][159][160]. According to the codon bias of the host cell, the 
respective protein sequence is translated back into the DNA sequence, selecting only the 
most frequently used tRNAs of the respective organism. The use of plasmids free of 
CpG dinucleotides has been reported to minimize inflammation and provide prolonged 
transgene expression [161]. On the other hand, CpG dinucleotides in the EC have 
conversely been demonstrated to provide improved transgene expression in mouse 
tissue [162].  
3.5.2.1 Applications of plasmid-based transgene technologies 
Optimizing plasmid DNA not only promotes gene therapy applications. It also benefits 
plasmid DNA vaccination strategies [163] and transfection of mammalian cells providing 
for recombinant protein production [164]. Conventionally, transient expression or 
random integration techniques are used for recombinant protein expression. These 
approaches however usually result in random integration and irreproducible levels of 
gene expression. To overcome these problems, stable integration systems have been 
developed that generate stable mammalian cell lines with defined integration sites and 
reproducible level of protein expression [165]. The Flp-In recombinase system which is 
based on the site-specific recombinase (Flp) from Saccharomyces cerevisiae offers a 
single targeted integration site, has been used for applications like the production of 
antibodies [166][167] or vaccine immunogens [168]. Initially, this site specific integration 
system was developed for basic research to study and compare transcriptional reporter 
gene activities as it allows the expression of numerous reporter gene constructs at an 
identical genomic location [165]. It is therefore a useful tool to investigate the impact of 
regulatory plasmid vector elements on transgene expression in the host cell. 
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There are many different plasmid DNA modification approaches to enhance transgene 
expression. However, to systematically generate improved expression vectors, the 
complex regulation of transgenes within the host cell has to be unraveled. A 
substantiated knowledge of epigenetic control, chromatin dynamics, DNA binding 
effectors and the contribution of sequence elements is essential to gain a more 
comprehensive picture of transgene regulation in eukaryotic cells. 
 Overview of preceding CpG studies 3.6
Previous studies in our research group demonstrated a direct influence of intragenic 
CpG frequency on gene expression [169][170]. With the use of selected reporter genes, a 
recurring effect has been observed: The depletion of intragenic CpG content results in 
repressed gene expression, whereas the augmentation of intragenic CpG dinucleotides 
increases gene expression.  
 The model genes hgfp and mmip-1α 3.6.1
The green fluorescent protein (GFP), originating from the jellyfish Aequorea Victoria, 
has the ability to emit fluorescence. This feature makes GFP a popular marker for gene 
expression. A synthetic version of gfp has been adapted to human codon usage, denoted 
as humanized hgp (hgfp) [171]. The increase of the CAI in the transgene sequence 
positively influences the efficiency of protein translation [160]. The CAI is a measure of 
directional synonymous codon usage bias of a given protein coding gene sequence in a 
given host organism. hgfp was used as a reporter gene in previous studies [169] and in 
the present study.  
 
The second model gene used in this study codes for the murine macrophage 
inflammatory protein (mMIP-1α), which belongs to the large family of cytokines. 
Cytokines are small, multifunctional proteins that play critical roles in the regulation of 
the body’s responses to diseases and infection. Among the clinical applications for 
cytokines are cancer immunotherapy [172], wound healing [173], allergy relief [174], 
animal health, [175], treatment of autoimmune disorders [176], and disease diagnosis 
[177]. The growing demand for human recombinant therapeutics is constantly 
promoting the development of enhanced expression systems. The generation of efficient 
expression vector systems is a major strategy towards this aim. Thus, mmip-1α has been 
chosen to serve as a model gene for previous studies [170] and the study at hand.  
 
mmip-1α and hgfp have been subjected to multiple modifications with respect to codon 
adaptation to human cells and their intragenic CpG content. hgfp contains 60 CpG 
dinucleotides [171] and is referred to as hGFP-60 in the work at hand. On the basis of this 
sequence, hGFP-0, lacking intragenic CpGs, was generated (Table 3A). 
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Table 3A | hgfp variants and sequence characteristics. CpG - Amount of CpG 
dinucleotides. GC% - Percentage of guanine-cytosine content. TpA - Amount of 
TpA dinucleotides. CAI – Codon adaptation index, which indicates the deviation of 
a given gene sequence with respect to a reference set of genes for predicted gene 
expression levels, regarding codon usage [160]. Modified from  [172].  
Gene variant  modification CpG GC % TpA CAI 
hGFP-0  depletion 0 55 15 0.93 
hGFP-60  optimization 60 61 15 0.96 
 
Table 3B | mmip-1α variants and sequence characteristics. CpG – Amount of 
CpG dinucleotides. GC% - Percentage of guanine-cytosine content. TpA - Amount 
of TpA dinucleotides. CAI – Codon adaptation index. Modified from  [170]. 
Gene variant  modification CpG GC % TpA CAI 
mMIP-wt  none 7  51  7  0.77  
mMIP-13  optimization 13  58  7  0.96  
mMIP-0  depletion 0  53  8  0.92  
mMIP-42  maximization 42  63  5  0.73  
 
 
The wild type sequence of mmip-1α was initially adapted to maximal codon quality 
thereby obtaining 13 CpGs, denoted as mMIP-13. On the basis of mMIP-13, the nucleotide 
sequence was further adapted to quantitatively deplete CpGs (mMIP-0) or maximize 
(mMIP-42) the intragenic CpG content within the ORF (Table 3B).  
 
For all hgfp and mmip-1α gene variants, alternative codons were used to maintain the 
amino acid sequence. Throughout this optimization process cryptic splice sites, TATA-
boxes and internal polyadenylation signals were avoided and neither codon distribution 
nor overall GC content or TpA amount were changed significantly. 
 
Figure 7 shows a schematic depiction of the used intron-free gene variants and the 
CpG dinucleotide distribution within the ORF. Depending on the type of experiment 
and host cell, gene variants were inserted into different eukaryotic and viral expression 
vectors, respectively, and were controlled by various promoters, as described in the 
result sections below. 
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Figure 7 I Schematic depiction of the hgfp and mmip-1α gene variants as 
inserted into the respective expression vector. Number and distribution of 
CpG dinucleotides within the ORF of hgfp (720bp) and mmip-1α (279bp) of the 
sense strand is shown. CpG dinucleotides are indicated as vertical lines true to 
scale. None of the genes contains introns. The gene variants are driven by 
different promoters and pA signals, as described in the respective section  
 Impact of intragenic CpG content of hgfp and mmip-1α on gene 3.6.2
expression  
Based on mmip-1α and hgfp gene variants, processes underlying differential gene 
expression levels have been investigated. Enhanced gene expression of CpG-rich genes 
was shown to be irrespective of mRNA export from the nucleus, splicing activities, 
altered RNA stability or translational modifications. By using different promoters (CMV, 
EF-1α) and cell lines (H1299, HEK 293, CHO) the observed effect was proven to be not 
cell type- or promoter-specific. The sum of the results indicated that the mechanisms 
responsible for changed gene expression occur at the level of gene transcription and are 
triggered by unmethylated CpG dinucleotides within the ORF [170][172]. Nuclear run on 
experiments confirmed that CpG depletion led to decreased de novo synthesized mRNA 
levels, whereas CpG maximization clearly enhanced de novo mRNA rates (Figure 8).  
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Figure 8 I Influence of CpG content on the de novo synthesis of hgfp (A) 
and mmip-1α (B) transcripts. The nuclear run-on assay was performed with 
stably transfected CHO Flp-In cells by supplying nuclei with biotin-16-UTP. 
Labelled transcripts were bound to streptavidin-coated magnetic beads and 
cDNA was synthesized by means of oligo-d(T)15-primed reverse transcription 
of captured molecules. Absolute cDNA copy numbers obtained from newly 
synthesized mRNA transcripts were quantified via LightCycler and 
normalized to ß-actin (hGFP) and hph (mMIP-1α) transcripts, respectively. 
Values were normalized to hgfp-0 and mmip-wt, respectively, which were set 
to 1. Results show the mean of 4 independent experiments each. Modified 
from [172] and [170] .  
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 Aim of the study 3.7
The present study was based on the positive correlation of transcription efficiency and 
CpG content previously observed with CpG-modified transgenes hgfp and mmip-1α 
[169][170][172](see chapter 3.6). The aim of this study was to shed light on the impact of 
intragenic CpG content on epigenetic control of hgfp and mmip-1α variants in 
mammalian cells. Stable transgene integration into CHO and HEK 293 cells using the 
flippase recombinase (Flp-In) technique provided the basis for detailed molecular 
analyses. Long term hGFP expression capacities in stable CHO Flp-In cells were to be 
investigated with respect to intragenic CpG content, promoters and under variable 
growth conditions. Transgene maintenance, DNA methylation and chromatin structure 
were to be compared between CpG variants depending on selection pressure. 
Nucleosome positioning abilities among transgene variants in vitro should give 
additional insights into CpG-induced effects on chromatin dynamics. Total and actively 
transcribing RNA Polymerase II occupancy between CpG variants were to be correlated 
to transcription rates in stably transfected HEK 293 Flp-In cells. Expression analysis of 
transgene CpG-chimera in CHO Flp-In cells containing CpG clusters in distinct 
intragenic regions should reveal positional relevance of CpG dinucleotides within the 
ORF.  
To evaluate transgene expression depending on intragenic CpG frequency in a gene 
therapy application suitable cell system, embryonic pluripotent stem cells of the line P19 
were to be transduced with lentiviral vectors containing the respective hgfp transgenes 
with differing CpG content. Expression analyses were to be conducted in P19 cells to 
reveal the impact of intragenic CpG dinucleotides in this system, which displays a high 
potential of epigenetic activity. In addition to varying CpG content, the cytomegalovirus 
(CMV) immediate early promoter, the human promoter for the elongation factor 1α (EF-
1α) and the ubiquitously acting chromatin opening element (UCOE) from the human 
HNRPA2B1-CBX3 locus (A2UCOE) were to be compared regarding their capacity to 
mediate high and stable transgene expression.  
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4  
 CpG-dependent differential transgene expression 4.1
using mammalian Flp-In cells 
To assess the impact of differential intragenic CpG content on long-term expression 
and regulation mechanisms, hgfp and mmip-1α gene variants were stably transfected 
into HEK (human embryonic kidney) 293 and chinese hamster ovary (CHO) cell lines 
using the flippase induced (Flp-In) recombination system [178]. CHO and HEK 293 
cell lines were chosen as they are widely used for recombinant protein production 
[179]. The Flp-In system allows site-specific integration of a single copy transgene 
[165]. This system makes the established cell lines suitable for comparisons between 
transgene variants and enables their analysis within the same genomic environment. 
Homologous recombination is mediated by the flippase recombinase, which is 
encoded by the plasmid pOG44. The flp recombination target (FRT) is located at a 
defined region of the cell genome and determines the integration location.  
hGFP and mMIP-1α expression was either driven by the cytomegalovirus (CMV) 
major immediate-early promoter or the human elongation factor 1α promoter 
(EF-1α), respectively. All gene variants have a Kozak sequence upstream of the start 
codon and are followed by the polyadenylation site of the bovine growth hormone 
(BGH pA), which is essential for the nuclear export, translation and stability of 
mRNA [180]. All expression cassettes have been inserted into the pcDNA5/FRT 
expression vector followed by stable Flp-In integration into HEK 293 and CHO cells, 
respectively.  
 
The plasmid pcDNA5/FRT contains a hygromycin resistance gene (hph) lacking the 
ATG start codon. Therefore, hygromycin expression is not initiated until hph is 
brought in frame with the ATG codon located in the Flp-In host genome. This system 
allows the selection of stable transfectants in CHO and HEK 293 cells when exposed 
to culture medium supplemented with hygromycin B. The site-specific integration of 
mmip-1α or hgfp in cells was confirmed by PCR with primers flanking the respective 
ORF and by X-gal staining (not shown). If the gene of interest is correctly integrated, 
the genomic lacZ gene loses its functionality. Approximately four weeks after 
successful transfection, ß-galactosidase activity could no longer be detected in any of 
the transfectants. Upon stable integration, hGFP expression was analyzed by flow 
cytometry, and mMIP-1α production was assayed by enzyme linked immunosorbent 
assay (ELISA) (Figure 9).  
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Figure 9 I Expression analyses of stably transfected CpG variants 
hgfp and mmip-1α. (A) hGFP expression of CHO Flp-In cells stably 
expressing the respective gene variant driven by the CMV promoter was 
assayed by flow cytometry. The mean fluorescent intensity (MFI) of 
hGFP positive cells (hGFP
+
) is shown. (B) mMIP-1α concentration in the 
medium supernatants of HEK 293 Flp-In cells stably expressing the 
respective gene variant driven by the CMV promoter was measured. 
The charts show the mean of three measurements each; standard 
deviations are indicated as error bars. 
 
In accordance with results obtained in previous studies [169][170][172], transgene 
expression was decreased upon CpG depletion in hgfp and mmip-1α, whereas 
intragenic CpG accumulation in mmip-1α led to a significant increase in protein 
levels. CpG depletion in hgfp resulted in a 6-fold decreased gene expression 
compared to the respective CpG-rich gene variant, exemplarily shown for CHO 
Flp-In cells and mediated by the CMV promoter in Figure 9A. For mMIP-1α, 
CpG depletion led to an almost complete loss of gene expression in stably transfected 
HEK 293 Flp-In cells, when driven by the CMV promoter (Figure 9B). By contrast, 
CpG maximization in mMIP-42 could achieve a more than 5-fold increase of wild 
type protein amount. 
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 Long-term hGFP expression in the presence or absence of 4.1.1
selection pressure 
The Flp-In system used for expression studies of CpG variants ensures stable 
insertion of a single copy of the transgene at a specific genomic location within a 
chromatinized setting that resembles that of a transcriptionally active environment 
[165]. This allows the interaction of epigenetic mechanisms surrounding the Flp-In 
target region with the integrated transgene. Sustainability of transgene expression in 
Flp-In cell lines is usually maintained by the application of selective antibiotic 
pressure. To resist the antibiotic pressure, the hygromycin resistance gene (hph) is 
expressed at high rates. Since hph is located 2.7kb upstream of the transgene-driving 
promoter, the chromatin structure at the promoter and ORF of CpG variants might 
remain permissively open and the DNA unmethylated due to the constant and high 
hph transcription upstream. It was hypothesized that intragenic CpG dinucleotides 
might negatively affect expression levels upon selection pressure removal due to 
intragenic transgene methylation and chromatin compaction. To address this issue, 
CHO Flp-In cells stably transfected with hgfp variants were maintained either with 
(+ hygromycin) or without (- hygromycin) selection pressure over the course of one 
year (Figure 10). After one year of regular measurements, these two cell groups, each 
stably expressing either hGFP-0 or hGFP-60, were compared with regard to 
expression efficiency and in correlation to DNA methylation and chromatinized 
state. To determine a possible impact of promoter origin (cellular versus viral), 
expression capacities of CMV and EF-1α promoter-driven gene transcription were 
examined in parallel.  
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Figure 10 I hGFP long-term expression of 
stably transfected CHO Flp-In cells 
cultured with or without selection 
pressure as analysed by flow cytometry. 
The expression level of polyclonal CHO Flp-
In cells stably transfected with hgfp variants 
driven by the CMV and the EF-1α promoter, 
respectively, with or without selection 
pressure by hygromycin was measured over 
the course of one year. The percentage of 
hGFP positive cells (A and C) and the MFI of 
hGFP positive cells (B and D) were 
measured weekly. The mean of two in 
parallel cultivated cell lines each is shown; 
standard deviations are indicated as error 
bars. 
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Upon abolishment of selection pressure, a slow but gradual decrease in expression 
efficiency could be observed in cell lines of both transgenes (Table 4). The amount of 
hGFP expressing CHO Flp-In cells was almost constantly 100% when cultivated under 
selection pressure and could even be maintained in a high percentage of CHO Flp-In 
cells until one year after selection pressure abolishment: at this time point, hGFP 
expression by hGFP-0 was still observed in 54% (CMV-promoter controlled) and 50% 
(EF-1α-promoter controlled) of the respective cell line, whereas expression by hGFP-
60 was still observed in 67% (CMV-promoter controlled) and 64% (EF-1α-promoter 
controlled) of CHO Flp-In cells. The mean fluorescence intensity (MFI) of the 
remaining hGFP expressing cells was measured accordingly. In the presence of 
selection pressure, the MFI of hGFP-0 was decreased to 41% (CMV-promoter driven) 
and 32% (EF-1α-promoter-driven), whereas hGFP-60 expression was diminished to 
46% (CMV-promoter driven) and 69% (EF-1α-promoter-driven) of the respective 
gene expression level at the start of the experiment. Without selection pressure, 
hGFP-0 expression decreased to 34% (CMV-promoter driven) and 22% (EF-1α-
promoter-driven) of the initial MFI; hGFP-60 was diminished to 16% (CMV-promoter 
driven) and 69% (EF-1α-promoter-driven) of the initial MFI. The ratios of remaining 
hGFP expressing cells and MFIs are summarized in Table 4. 
 
Table 4 I Percentage of hGFP
+ 
cells and MFI of cells after one year of 
cell cultivation (with or w/o selection pressure) compared to hGFP
+ 
cells 
and MFI at the start of the experiment. 
Promoter Selection pressure Gene variant % hGFP
+
 cells % of initial MFI 
 
CMV 
yes 
hGFP-0 100% 41% 
hGFP-60 100% 46% 
no 
hGFP-0 54% 34% 
hGFP-60 67% 16% 
 
EF-1α 
yes 
hGFP-0 100% 32% 
hGFP-60 100% 69% 
no 
hGFP-0 50% 22% 
hGFP-60 64% 69% 
 
 
Surprisingly, intragenic CpG dinucleotides did not lead to accelerated gene silencing 
compared to CpG-lacking gene variants. Instead, the reduction of hGFP positive cells 
occurred even faster in hGFP-0, as reflected by the amount of remaining hGFP 
expressing cells. hGFP expression efficiency of hGFP positive cells, quantified as the 
MFI, however decreased faster in cell lines expressing hGFP-60 compared to hGFP-0 
when controlled by the CMV promoter. Contrary and most notably, hgfp 
transcription driven by the EF-1α could resist gene silencing more effectively with an 
increased intragenic CpG content.  
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 Sorting of CHO Flp-In cells according to hGFP expression 4.1.2
levels  
To shed light on the mechanism responsible for decreased gene expression over the 
course of time, hgfp variants were analyzed with regard to transgene control 
mechanisms. Since the loss of function was most pronounced in transgenes mediated 
by the CMV promoter, cells harboring transgenes driven by the EF-1α promoter were 
excluded from these analyses. CHO Flp-In cells expressing hGFP-0 and hGFP-60 
cultivated without selection pressure were subjected to fluorescence activated cell 
sorting (FACS) one year after withdrawal of selection pressure. Cells of each cell line 
(hGFP-0 and hGFP-60) were sorted into the subpopulations “no”, moderate (“mod”) 
and maximum (“max”) gene expression (Figure 11).  
 
A B 
  
C D 
  
Figure 11 I Sorting of hGFP expressing CHO Flp-In cells into 
subpopulations according to their expression levels by FACS after 
one year of cell cultivation. Only viable single cells (A) were analyzed. 
Threshold for hGFP expressing cells was set according to the mock 
control (non-transfected CHO cells) (B). Cells below this threshold were 
regarded as hGFP negative (no expression). For hGFP-0 (C) and hGFP-
60 (D), thresholds dividing moderately (mod) from maximal (max) 
expressing cells were set arbitrarily.  
After sorting, the respective cell populations were cultivated without selection 
pressure for another two days to obtain enough cell material for subsequent analyses. 
Thereafter, genomic DNA of each of the cell-fractions was isolated for determination 
of hgfp copy numbers and investigation of the methylation status at the CMV 
promoter and ORF of hgfp.  
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 Relative copy number and methylation status of hgfp in 4.1.3
correlation to expression levels 
Two reasons were conceivable to be responsible for the decrease in gene expression 
over the course of time. i) The missing selection pressure by the hph transcription 
stop led to transgene loss, either by ejection of the transfected plasmid at the Flp-In 
sites or by the outgrowth of cells that do not contain the transgene. ii) Alternatively, 
the transgenes were subjected to gene silencing via epigenetic regulation. 
To address this issue, relative hgfp copy numbers of the respective cell 
populations, cultivated in the presence or absence of selection pressure, and sorted 
according to their expression levels, were compared. hgfp copy numbers of all cell 
populations were quantified relative to endogenous ß-actin by real-time PCR and 
normalized to hGFP-0 cultivated under selection pressure (Figure 12).  
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Figure 12 I Determination of hgfp copy numbers relative to ß-actin of CHO Flp-In 
cells stably expressing hGFP variants with or w/o selection pressure. Genomic 
DNA of cells sorted into the subpopulations no, moderately (mod) and maximal 
(max) gene expression was isolated and subjected to quantitative PCR. Primers 
encompassing the TSS of hgfp were used to determine the copy numbers of hgfp 
transgenes. All Ct values were normalized to the corresponding Ct values of ß-actin. 
hGFP-0 expressed under selection pressure was set to the value 1; the remaining 
gene variants were scaled accordingly. The mean and standard deviations of two 
DNA preparations of triplicates each are shown. Significance was calculated using 
ANOVA/Tukey’s Multiple Comparison Test (*p<0.05; **p<0.01; ***p<0.001). 
Primers encompassing the transcription start site (TSS) were used instead of the ORF 
to avoid different primer efficiencies due to different template sequences between 
hgfp variants. The quantification of relative hgfp copy numbers revealed that the 
removal of selection pressure did not lead to changed transgene copy numbers in 
moderately and maximally hGFP expressing cell populations, compared to CHO 
Flp-In cells maintained under selection pressure. This was shown for both hGFP-0 
and hGFP-60. This result was expected as the threshold for both moderate and 
maximal hGFP expression was set above the fluorescence level of the mock control. 
By contrast, the cell fractions sorted into the category ‘no expression’ exhibited a 
decreased hgfp copy number in comparison to cells exhibiting higher levels of hGFP 
expression. While hgfp transgenes were retained in 58% of cells transfected with 
hGFP-60, only 32% of hGFP-0 transfected cells contained the hgfp transgene after 
one year of selection pressure abolishment. The fact that a subset of cells exhibited 
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complete deficiency of hGFP expression and yet still contained the transgene implies 
that the loss of function must additionally be due to epigenetic repression. 
 
Isolated genomic DNA of cell populations used for copy number determination 
was simultaneously used for evaluation of the methylation state of hgfp. To this end, 
genomic DNA was subjected to bisulphite genomic sequencing following a published 
protocol [181]. Sodium bisulphite selectively deaminates unmethylated cytosines to 
uraciles, whereas methylated cytosines stay unchanged. In the subsequent PCR 
reaction, uraciles are replaced by thymines resulting in a C to T conversion. To 
validate the method, the pcDNA5 plasmid containing hgfp-60 (phGFP-60) was 
subjected to quantitative in vitro methylation prior to bisulphite sequencing. 
Chromatograms were evaluated using the software Chromas. The methylation levels 
of CpG dinucleotides were determined by measuring the ratio of each of the cytosine 
peak heights to the sum of respective cytosine and thymine peak heights in 
automated DNA sequencing traces, according to a technique published by Jiang et al 
[182]. 
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Figure 13A I Methylation levels of the CMV promoter. Genomic DNA of CHO Flp-In cells expressing hGFP 
variants with selection pressure and CHO-hGFP cells w/o selection pressure sorted into the fractions no, 
moderate (mod) and maximum (max) gene expression was isolated and subjected to bisulfite sequencing. 
In vitro methylated phGFP-60 served as a positive control. The methylation level is reflected by the size of the 
bubbles, as shown in the scale above the diagram. Numbers above the charts represent the distance from the 
hgfp start codon. Examined cell lines are characterized below the diagrams. The methylation level of CpGs was 
determined by measuring the ratio of the cytosine peak height to the sum of cytosine and thymine peak 
heights in automated DNA sequencing traces [182].  
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Figure 13B I Methylation levels of the hgfp ORF. Genomic DNA of CHO Flp-In cells expressing hGFP 
variants with selection pressure and CHO-hGFP cells w/o selection pressure sorted into the fractions no, 
moderate (mod) and maximum (max) gene expression was isolated and subjected to bisulfite sequencing. 
In vitro methylated phGFP-60 served as a positive control. The methylation level is reflected by the size of the 
bubbles, as shown in the scale above the diagram. Numbers above the charts represent the distance from the 
hgfp start codon. Examined cell lines are characterized below the diagrams. The methylation level of CpGs 
was determined by measuring the ratio of the cytosine peak height to the sum of cytosine and thymine peak 
heights in automated DNA sequencing traces [182].  
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The graphic charts of chromatogram evaluations revealed substantial differences in 
methylation levels between different cell populations according to their expression 
levels (Figure 13 A, B). While cells expressing hGFP-0 and hGFP-60 cultivated in the 
presence of selection pressure exhibited virtually no methylation neither in the 
promoter nor in the ORF (in case of hGFP-60), cells cultivated in the absence of 
selection pressure showed gradually increasing levels of DNA methylation both in the 
promoter and in the ORF. The overall methylation levels (Table 5) for the CMV 
promoter mediating hGFP-o expression were 4.8% (maximum expression), 5.1% 
(moderate expression) and 20.2% (no expression). For the CMV promoter controlled 
hGFP-60 expression, the evaluation yielded 5.4% (maximum expression), 23% 
(moderate expression) and 35.9% (no expression) of methylated CpGs. The ORF of 
hgfp exhibited an overall methylation of 0.5% (maximum expression), 24.3% 
(moderate expression) and 44.7% (no expression). It has to be noted that the DNA 
isolation for bisulfite treatment was conducted two days after the cell sorting. Thus, 
the expression profile might have undergone slight changes compared to the day of 
DNA sorting. Cytosines of in vitro methylated phGFP-60 were virtually completely 
resistant to bisulphite treatment, resulting in 90% (CMV promoter) and 95% (ORF) 
of overall cytosine methylation, respectively. While the methylation levels in the 
promoter is highest at the borders and lower in the center, CpG methylation in the 
ORF of hgfp is highest in the 5’ end and gradually decreases towards the 3’ end. In in 
vitro methylated phGFP-60, CpG dinucleotides are methylated evenly.  
 
Table 5 I Summary of methylation levels of the CMV promoter and hgfp ORF, 
displayed as bubble chart in Figure 13, and relative hgfp copy no as quantified by real-
time PCR, with hGFP-0 cultivated under selection pressure set to the value 1 (see 
Figure 12). 
Description of cell line Methylation level [%]  
Selection 
pressure 
Gene variant Relative expression level CMV promoter ORF of hgfp 
relative 
copy no (qPCR) 
yes 
hGFP-0 low < 1 - 1 
hGFP-60 high < 1 < 1 0.9 
no 
hGFP-0 
maximal (max) 4.8 - 0.9 
moderate (mod) 5.1 - 1 
no expression (no) 20.2 - 0.3 
hGFP-60 
maximal (max) 5.4 0.5 0.9 
moderate (mod) 23.1 24.3 0.8 
no expression (no) 35.9 44.7 0.6 
- phGFP-60 positive control 90.2 94.8  
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The decline of hGFP expression in the absence of selection pressure therefore seems 
to be a combination of both transgene loss and DNA methylation of the expression 
cassette, as can be seen from Table 5. Methylation occurred in cytosines of the 
promoter and the ORF. While hGFP-0 provides no methylation targets in the ORF, 
hGFP-60 can be methylated at both the promoter and the ORF. The ratio of 
methylated cytosines in the promoter was higher in hGFP-60 compared to hGFP-0. 
In particular the moderately hGFP expressing cell fraction displayed a more than 
4-fold higher methylation rate in the CMV promoter driving hGFP-60 compared to 
the CMV promoter controlling hGFP-0. Hence, loss of function (“no hGFP 
expression”) in hGFP-0 resulted only 20% from DNA methylation and approximately 
70% (according to the relative copy no of 0.3; see Table 5) from transgene loss. 
Contrarily, loss of function by hGFP-60 was achieved by 36% methylation in the 
promoter and an additional 45% in the ORF. According to the relative copy no of 0.6 
(Table 5), only 40% of cells have lost the transgene hGFP-60. Due to extensive 
silencing, cells containing hGFP-60 less readily lost the transgene compared to hGFP-
0 harbouring cells.   
 Impact of intragenic CpG dinucleotides on chromatin 4.1.4
structure 
Since DNA methylation is frequently accompanied by chromatin changes, it was 
investigated whether the observed differences in expression efficiency are reflected 
by changes in chromatin density. 
4.1.4.1 Chromatin structure of hgfp variants in vivo 
At the time point of copy number determination and methylation analysis, stably 
hGFP expressing CHO Flp-In cells cultivated in the presence, respectively absence of 
selection pressure were subjected to FAIRE (Formaldehyde Assisted Isolation of 
Regulatory Elements). Out of the cell population cultivated without selection 
pressure, the fraction of repressed hGFP expression (denoted as “no expression”) was 
examined. By FAIRE, chromatin is cross-linked with formaldehyde, sheared to 
fragments of 200-500bp by sonication, and phenol-chloroform extracted. This 
procedure results in preferential enrichment of nucleosome-depleted genomic 
regions that can be quantified by real-time PCR. The assay was performed at the 
transcription start site (TSS) and the ORF (position +32 to +152 relative to the start 
codon) of the respective gene variant. A region between the 4th and 5th exon of the 
housekeeping gene ß-actin served as a comparison control. All values were 
normalized to genes coding for rRNA (rdna). The fraction of FAIRE-extracted DNA 
was found to be generally higher at both the TSS and ORF of hgfp compared to the 
corresponding ß-actin control (Figure 14). This reflects the particularly open 
chromatin environment at the Flp-In recombination target site containing the 
respective CpG gene variant.  
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Figure 14 I Inverse chromatin densities of CHO Flp-In cells stably expressing 
hGFP variants in vivo as analyzed by FAIRE. Enrichment for nucleosome-
depleted chromatin by FAIRE extraction was performed, and DNA from the 
aqueous phase was quantified by real-time PCR using primer pairs specific for 
(A) the TSS (-87 to -17 relative to the start codon) and (B) a region of the hgfp 
ORF (+32 to +152 relative to the start codon). A region between the 4
th
 and 5
th 
exon of ß-actin served as a control. The mean and standard deviation of ß-actin 
values of all four cell lines is shown. The values are presented as the ratio of DNA 
recovered from cross-linked cells divided by the amounts of the same DNA in 
the corresponding non-cross-linked samples. All results were normalized to rdna 
and referred to hGFP-0 cultured under selection pressure, which was set to the 
value 1. The data reflect the degrees of nucleosome depletion in the respective 
genomic regions. The mean and standard deviations of two FAIRE preparations 
with a duplicate each are shown. Significance was calculated using 
ANOVA/Tukey’s Multiple Comparison Test (* p<0.05).The colors of the bars 
reflect the respective cell populations in Figure 10. 
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The amount of extracted nucleosome-free DNA detected at the TSS and ORF of hgfp 
clearly correlated with the presence of selection pressure. Thus, abolishment of 
selection pressure not only induced DNA methylation but also a significantly 
increased chromatin density at the TSS of hGFP-0 and hGFP-60. Quantification of 
isolated nucleosome-free DNA in the ORF not only revealed an association with 
selection pressure. It furthermore showed a significantly higher degree of chromatin 
density at the ORF of hGFP-0 relative to hGFP-60 (ANOVA; p<0.05). This relative 
difference was clearly visible in CHO Flp-In cells cultivated under selection pressure, 
but was not observed in CHO Flp-In cells in which hGFP expression was repressed 
due to the absence of antibiotic selection. Thus, intragenic CpG depletion led to a 
higher chromatin density at hgfp in CHO Flp-In cells growing under selective 
conditions, thereby supposedly impeding transcription efficiency, whereas a high 
intragenic CpG content maintained an open chromatin structure. Upon selection 
pressure withdrawal, the chromatin opening abilities of intragenic CpG dinucleotides 
seem to get lost.   
4.1.4.2 Chromatin structure of mmip-1α variants in vivo 
In order to verify the association of transcription efficiency and chromatin structure 
among genes differing in intragenic CpG content, FAIRE was analogously performed 
in HEK 293 Flp-In cells stably expressing the mMIP-1α variants mMIP-wt, mMIP-13, 
mMIP-0 and mMIP-42 (Figure 15). Due to the highly divergent DNA sequences 
among the variants, primers were used binding to regions in direct proximity to the 
ORF, to avoid a bias by different primer efficiencies. Hence, the transcription start 
site (TSS) and the 3’untranslated region (3’UTR) immediately downstream of the 
respective mmip-1α variant were examined. The second exon-intron junction of the 
housekeeping gene ß2-microglobulin (ß2-m) was used as an endogenous control and 
all values were normalized to rdna. In all of the cell lines, a large amount of FAIRE-
extracted DNA was observed from both the TSS and the 3’UTR of mmip-1α compared 
to the constitutively expressed ß2-m. This indicates a very open chromatin structure 
at the mmip-1α locus of all gene variants, as was already shown by CHO Flp-In hgfp 
variants. While mMIP-wt, mMIP-13 and mMIP-42 exhibited very similar levels of 
nucleosome density, mMIP-0 revealed a significantly denser nucleosome occupancy 
at the TSS and 3’ UTR compared to the rest of mMIP-1α variants (ANOVA; p<0.05). In 
accordance with hgfp FAIRE analyses, increased chromatinization correlated with 
transcription loss resulting from CpG depletion. However, no correlation could be 
detected between transcription efficiency and chromatin density between the 
wild type and CpG-maximized mMIP-42. It is assumed that the additional 
accumulation of CpGs within the ORF of mMIP-42 did not lead to lower chromatin 
density due to saturation effects of the already very open chromatin structure at the 
Flp-In recombination locus.  
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Figure 15 I Inverse chromatin densities of HEK 293 Flp-In cells stably 
expressing mMIP-1α variants in vivo as analyzed by FAIRE. Enrichment for 
nucleosome-depleted chromatin by FAIRE extraction was performed, and DNA 
from the aqueous phase was quantified by real-time PCR using primer pairs 
specific for (A) the TSS (-87 to -17 relative to the start codon) and (B) a region 
10bp to 97bp downstream of the ORF stop codon (3’ UTR). The 2
nd
 exon-intron 
junction of ß2-microglobulin (ß2-m) served as a control. The mean and standard 
deviation of ß2-m values of all four cell lines is shown. The values are presented 
as the ratio of DNA recovered from cross-linked cells divided by the amounts of 
the same DNA in the corresponding non-cross-linked samples. All results were 
normalized to rdna and referred to mMIP-wt, which was set to the value 1. The 
data reflect the degrees of nucleosome depletion in the respective genomic 
regions. The mean and standard deviations of two FAIRE preparations with a 
duplicate each are shown. Significance was calculated using ANOVA/ Tukey’s 
Multiple Comparison Test (* p<0.05). 
4.1.4.3 H3K4me3 occupation of mmip-1α variants 
The correlation between intragenic CpG depletion and increased chromatin density 
raised the question of which histones or histone modifications might be involved in 
the observed chromatin changes. The histone modification of H3 tri-methylated at 
lysine 4 (H3K4me3) is strongly and preferentially associated with transcribed regions 
of active genes [183]. It was further shown to co-localize with CpG islands and 
regulators of active gene transcription, such as the CpG-binding protein CFP1 [107]. 
Due to these features, Chromatin Immunoprecipitation (ChIP) was used to examine 
whether H3K4 was selectively trimethylated at CpG enriched regions. Occupation of 
histone H3, representing one of the five basal histones of the nucleosome served as a 
control. Chromatin was cross-linked with formaldehyde, sheared to fragments of 
300-800bp by sonication and the DNA fragments were precipitated with the 
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according antibodies (see Material and Methods). Quantitative PCR following ChIP 
was conducted at the CMV promoter and 3’UTR of HEK 293 Flp-In cells stably 
expressing the respective mMIP-1α variants. The first exon-intron-junction of gapdh 
was used as a control. The results are presented as relative output-to-input, mmip-1α 
to gapdh (H3) ratios, or H3K4me3/H3, respectively.  
Figure 16 shows that all gene variants were less occupied by H3 and H3K4me3 at 
the 3’UTR and CMV promoter region than the control region of the housekeeping 
gene gapdh. This observation affirms the high level of nucleosome depletion of all 
gene variants already detected by FAIRE. In contrast to FAIRE analyses, the 
differences of chromatin density as reflected by H3 occupancy were not significantly 
different between the mmip-1α variants. The same situation applied for H3K4me3 
precipitates. One reason for these discrepancies between chromatinization levels 
detected by FAIRE and ChIP might be due to the higher sensitivity of the FAIRE 
assay. During ChIP performance optimization, a fragment size not smaller than 300-
800bp of sonicated genomic DNA was determined to be required for successful DNA 
precipitation by ChIP. In contrast, fragment lengths of only 200-500bp was sufficient 
to obtain enough template for FAIRE analyses. Due to the short length of the CMV 
promoter (588bp) and mmip-1α (279bp), ChIP fragments might have been too large 
to reflect the actual H3-binding at the promoter and 3’UTR, but rather the H3-
binding of proximal regions, which are most likely more intensively occupied by 
histones. 
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Figure 16 I ChIP analysis of H3 (A,B) and H3K4me3 (C,D) at the promoter and 
3’UTR of mMIP-wt, mMIP-13, mMIP-0 and mMIP-42. ChIP was performed by 
cross-linking of HEK 293 Flp-In cells stably expressing mMIP-1α variants, 
sonication, incubation with the appropriate antibody and isolation of bound 
DNA by sepharose A beads. After precipitation DNA was quantified by real-time 
PCR using primer pairs specific for the CMV promoter and the 3’UTR 
immediately downstream of the stop codon. The first exon-intron-junction of 
gapdh was used as internal control. Results for the promoter and 3’UTR were 
either expressed as input to output ratio (A;C) or normalized to gapdh (C). 
H3K4me3 values were normalized to H3 (D). Normal polyclonal rabbit IgG served 
as a negative control. The mean-IgG levels of all cell lines were either expressed 
as input to output ratio of the respective gene locus (A;C) or subtracted from the 
ChIP results of the corresponding precipitated protein (B;D). The mean and 
standard deviation of three independent experiments is shown. 
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4.1.4.4 Influence of CpG dinucleotides in hgfp on nucleosome positioning in 
vitro 
The observation of changed chromatin density between CpG variants detected by 
FAIRE led to the question whether the positioning of nucleosomes was affected by 
CpG dinucleotides as well. Sequence patterns can directly affect nucleosome 
positioning by determining biophysical properties of DNA like the bending flexibility 
around a histone octamere [184]. It was therefore hypothesized that sequence 
modifications in the ORF act via an altered nucleosome binding to change 
transcription performance. To analyze impaired DNA-histone interactions among 
CpG variants, in vitro nucleosome reconstitution assays were performed.  
Mononucleosomes were formed mixing histone octamers and PCR fragments 
spanning distinct regions of the ORF of hGFP-0 and hGFP-60, respectively, by salt 
dialysis [185]. Nucleosome positions were resolved by native polyacrylamid gel 
electrophoresis (PAGE) and detected by ethidium bromide staining followed by 
ultraviolet exposure. The ORF of hgfp comprises 720bp. Due to its length, a fragment 
comprising the entire gene would form polynucleosomes when assembled with 
histone octamers that cannot be resolved by native PAGE. Hence, hgfp was 
partitioned into the three fractions I, II and III with approximately the same CpG 
content (22, 21 and 24 CpGs), which were generated by PCR. Primers were designed 
to amplify overlapping fragments of 280 to 300bp within the ORF of hgfp (Figure 17).  
 
Figure 17 I Amplification of hGFP fragments I, II and III. Three 
fragments of similar length, hGFPI (300bp), hGFPII (280bp) and hGFPIII 
(299bp), indicated as dashed lines, were amplified. The ORF of hgfp is 
represented by a grey bar. Primers are marked as arrows. Sequence 
positions are indicated relative to the TSS [186]. 
 
The position of a histone octamere within the DNA fragment affects its 
electrophoretic mobility: centrally located nucleosomes migrate slower than 
nucleosomes located at the end of a DNA fragment. Once the optimal histone: DNA 
ratio was established by a test assembly (not shown) nucleosome reconstitutions 
were performed with each of the DNA fragments. Comparative analysis of 
mononucleosome band patterns revealed different positioning preferences among 
the gene variants (Figure 18).  
+ 38 + 337
+ 297 + 576
+ 541 + 839
hGFP I
hGFP II
hGFP III
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Figure 18 I Nucleosome positions among variant hGFP fragments. hGFP 
fragments I, II and III (see Figure 17) were reconstituted into nucleosomes, 
followed by native PAGE, ethidium bromide staining and UV detection. The 
CpG frequency of each fragment is denoted in the fragments annotation 
above each PAGE illustration. Bands representing nucleosome positions 
that are specified in the text below are indicated as black arrows. One 
representative set out of two reconstitutions is shown [186]. 
Both hGFP I variants preferably bound histones in a central region (IA). The 
distinctiveness of nucleosome binding is more defined in hGFP-o than in hGFP-22. 
hGFP II variants were mostly occupied by histones at the 5' or 3' end of the fragments 
(IIB), whereas central regions were bound very unspecifically (IIA). Despite favoring 
histone binding within the same regions (IIIA-D), the preference for certain histone 
locations seems to vary between the two fragments hGFP-0 III and hGFP-24 as 
judged by the respective band intensities. The results clearly demonstrate that CpG-
variations in hGFP directly affect nucleosome-positioning abilities in vitro.  
 Influence of intragenic CpG dinucleotides on RNAPII 4.1.5
occupation  
The observation that intragenic CpG dinucleotides alter chromatin structure in a 
manner that apparently correlates with gene transcription led to the question 
whether these changes coincide with a changed RNA Polymerase II (RNAPII) 
occupancy and transcription rate. Due to the broader spectrum of CpG frequencies 
among mmip-1α compared to hgfp variants, mmip-1α transgenes were used as model 
for this experiment. The C-terminal domain (CTD) of RNAPII becomes multiply 
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phosphorylated upon initiation. Phosphorylation of the serin-2 residue occurs when 
RNAPII is associated with the coding region and has been implicated in productive 
elongation and the 3′-end processing of the transcript [19]. Commercially available 
antibodies directed against different CTD phosphorylation states therefore allow 
distinguishing between certain stages of the transcription cycle. 
To address whether transcriptional changes observed in CpG variants correlate 
with altered RNAPII-binding, HEK 293 Flp-In cells harboring the respective mmip-1α 
variants were subjected to ChIP. Chromatin was cross-linked with formaldehyde, 
sheared to fragments of 300-800bp by sonication and the DNA fragments were 
precipitated with the according antibodies (see Material and Methods). Quantitative 
PCR following ChIP was conducted at the CMV promoter and 3’UTR. The first exon-
intron-junction of gapdh was used as a control. The binding of total and 
transcriptionally active RNAPII was examined using antibodies raised against the N-
terminus of RNAPII and the CTD of RNAPII, phosphorylated at serine-2 (Ser2P Pol 
II), respectively. The results are presented as relative output-to-input ratios and 
mmip-1α to gapdh ratios, respectively. 
The evaluation of absolute RNAPII-bound values revealed an increased amount of 
RNAPII precipitated by mmip-1α transgenes compared to RNAPII bound at gapdh 
(Figure 19 A, C). This discrepancy is even more pronounced in Ser2 
RNAPII-precipitates. This result repeatedly confirms that the transgenes are situated 
in the transcriptionally active region of the recombination site.  
ChIP results normalized to endogenous gapdh demonstrate that total RNAPII-
binding at the promoter is not significantly changed between mMIP-wt, mMIP-13, 
mMIP-0 and mMIP-42 (Figure 19 B). At the 3’UTR, a trend of decreased RNAPII at 
mMIP-0 and increased RNAPII at mMIP-42 was observed compared to mMIP-wt and 
mMIP-13. To evaluate the fraction of bound Polymerase II that is actively engaged in 
elongation, relative quantification of Ser2P RNAPII at the promoter and 3’UTR was 
examined. In accordance with total RNAPII, similar amounts of Ser2P Pol II were 
detected at the promoter between mMIP-wt, mMIP-13 mMIP-0 and mMIP-42 and at 
the 3’UTR between mMIP-wt, mMIP-13 and mMIP-0 when normalized to gapdh 
(Figure 19D). In mMIP-42 however, a trend of increased Ser2P RNAPII occupancy 
could be observed. The correlation of increased Ser2P RNAPII occupancy at the 
3’UTR with increased mRNA transcripts in mMIP-42 implies that mMIP-42 exhibits a 
higher elongation rate than the CpG-reduced/-lacking gene variants. 
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Figure 19 I ChIP analysis of Pol II (A,B) and Ser2P RNAPII (C,D) at the 
promoter and 3’UTR of mMIP-1α variants. ChIP was performed by cross-
linking of HEK 293 Flp-In cells stably expressing mMIP-1α variants, sonication, 
incubation with the appropriate antibody and isolation of DNA loaded 
antibodies by sepharose A beads. After precipitation, DNA was quantified by 
real-time PCR using primer pairs specific for the CMV promoter and 3’UTR. The 
first exon-intron-junction of gapdh was used as internal control. Results for the 
promoter and 3’UTR were expressed as input to output ratio (A,C) or normalized 
to gapdh (B,D). Polyclonal rabbit anti-FLAG antibody served as a negative 
control. The mean-IgG levels of all cell lines were either expressed as input to 
output ratio of the respective gene locus (A;C) or subtracted from the ChIP 
results of the corresponding precipitated protein (B;D). The mean and standard 
deviation of three independent experiments and duplicates each is shown. 
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 Impact of intragenic CpG distribution on gene expression in 4.1.6
hgfp 
The ability of CpG dinucleotides to enhance elongation rates of mmip-1α led to the 
question whether a specific motif or region within the ORF of CpG variants was 
responsible for this effect. To shed light on the positional relevance of CpGs within 
the transgene ORF, chimeras were generated by fusion PCR to create genes with CpG 
clusters in distinct intragenic 5’ and 3’ regions of the ORF, respectively. hgfp was 
preferred over mmip-1α fragments for this experiment, since their ORF is 2.5 fold 
longer than mmip-1α. Thus, the position effect was assumed to be more pronounced.  
Based on hGFP-0 and hGFP-60, chimera illustrated in Figure 20, were created. 
Expression cassettes containing the gene-chimera were stably transfected into CHO 
Flp-In cells and expression levels were measured by flow cytometry exactly as was 
done in previous expression analyses. The protein levels observed generally 
correlated with the amount of intragenic CpG content (Figure 20, right panel). An 
exception to this trend was the chimera containing only 13 CpGs in the 5’ region. This 
variant conferred a higher gene expression than would be expected by its CpG 
frequency. 
 
 
0CpG
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5' 13CpG
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CpG distribution
0 10000 20000 30000
MFI
 
Figure 20 I Expression analysis of hgfp CpG-chimera. On the basis of hGFP-0 
and hGFP-60, gene chimera with different CpG distribution were generated by 
fusion PCR, followed by stable transfection into CHO Flp-In cells. hGFP 
expression of the respective gene variants was analyzed by flow cytometry. The 
mean and standard deviations of three measurements is shown. 
Correlating the expression efficiency (indicated by the MFI) to the CpG frequency, it 
becomes evident that the expression levels decrease with increasing distance of CpG 
dinucleotides from the start codon (Table 6). While hGFP-60 and hGFP containing 
25 CpGs in their 5’gene end achieved similar MFI/CpG frequency ratios, hGFP 
containing only 13 CpGs in the very 5’gene border revealed a 2-fold increased 
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MFI/CpG frequency over hGFP with 21 CpGs in the 3’gene end. Thus, not only the 
mere amount but also the proximity of CpG dinucleotides to the transcription start 
site significantly accounts for increased transcription rates. 
 
Table 6 I Ratio of MFI/CpG frequency of hGFP-60 
and gene chimera as depicted in Figure 20. 
 
  
Gene variant Ratio of MFI/CpG frequency 
hGFP-0 - 
hGFP-60 458 
5’ 25 CpG 545 
5’ 13 CpG 750 
3’ 21 CpG 343 
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 CpG-dependent differential transgene expression in 4.2
murine embryonic carcinoma cells P19 
The results presented in section 4.1 provided convincing evidence that an augmented 
CpG content within the ORF of hgfp and mmip-1α significantly increased gene 
transcription in mammalian Flp-In cells. Long-term hGFP expression analysis of 
stable CHO Flp-In cells demonstrated gradual but surprisingly slow decrease in 
transgene expression over the period of one year. The gene expression decline 
correlated with transgene loss, DNA methylation and a higher degree of 
chromatinization in vivo. The Flp-In cell system used in this study provided site-
specific integration of the respective transgenes within a transcriptionally active and 
epigenetically constant genomic environment under standardized conditions. Due to 
these abilities, the Flp-In system was the tool of choice to compare regulation 
mechanisms responsible for differential transcription efficiencies between 
CpG-variants. On the other hand, the consistent transgene integration into one 
specific genomic locus might restrict CpG-mediated mechanisms to a limited 
spectrum of epigenetic regulation. Moreover, the Flp-In system does not represent a 
relevant technique for gene therapy applications, the optimization of which is one of 
the long-term goals of this project. Instead, retro- and lentiviral vectors are 
frequently applied in gene therapy trials [187][188][189] and stem cells are the major 
source for regenerative medicine [190][191][192]. However, embryonic stem (ES) cells 
have a much higher potential of epigenetic activity than differentiated somatic cells 
[193]. Thus, expression sustainability by different regulatory transgene elements in ES 
cells has to be elaborately tested prior to their application. 
P19 embryonic carcinoma cells are pluripotent stem cells with a high potential for 
gene silencing [194]. P19 cells were therefore chosen to examine the sustainability of 
hGFP expression depending on intragenic CpG frequency and regulating elements. 
Self-inactivating lentiviral vectors (SIN-LVs) incorporating respective expression 
cassettes were used to introduce hgfp variants of different intragenic CpG content 
into P19 cells. Three different promoters were compared for their ability to confer 
expression of hGFP variants within this system: The CMV promoter, EF-1α promoter 
and ubiquitously acting chromatin opening element (UCOE) from the human 
HNRPA2B1-CBX3 locus (A2UCOE). A2UCOE was reported to sustain stable transgene 
expression in cell culture systems even in the absence of selection pressure, or when 
integrated into heterochromatin region [135].  
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 Generation of SIN-LVs incorporating hgfp variants 4.2.1
SIN-LVs were produced by transient transfection of HEK 293 cells with the envelope 
plasmid pcDNA3.1-VSV-G, the packaging plasmid psPAX2 and a LV plasmid 
containing either hGFP-0 or hGFP-60 mediated by the CMV, EF-1α or the A2UCOE 
promoter (Figure 21). 
 
 
Figure 21 I Schematic of the lentiviral transfer vectors used in this 
study. LTR - long-terminal repeat, RRE - rev-response element, Ψ - 
packaging signal, WPRE - Woodchuck hepatitis posttranscriptional 
regulatory element. The divergent transcription directions at the 
CBX3/HNRPA2B1 locus are indicated as arrows. The region covering the 
minimal 2.2-kb A2UCOE element [135] and the promoters CMV and EF-
1α control the transcription of hGFP-0 and hGFP-60, respectively.  
The titer of virus preparations was determined by transducing HEK 293 cells with 
serial dilutions of virus batches followed by quantification of hGFP expressing cells 
assayed by flow cytometry. The transduction of P19 cells by SIN-LVs incorporating 
the various constructs by an equal MOI as calculated from hGFP positive HEK 293 
cells resulted in different proportions of hGFP expressing P19 cells among the variant 
hGFP constructs. Titrations of different initial virus concentrations for the 
transduction of P19 cells were therefore necessary to reach a similar percentage of 
hGFP positive cells at the start of the experiment. An equal proportion of hGFP 
positive cells was desired to obtain a comparable baseline for the comparison of 
expressional changes over time. A low MOI was used to avoid the integration of 
multiple copies per cell. An exception to this had to be made for CMV-promoter 
containing vectors. In this case, a high MOI was required to reach the hGFP 
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detection limit and to obtain comparable proportions of hGFP positive cells 
(Table 7). hGFP expression was assayed every three days up to 20 days.  
 
Table 7 I Summary of used MOI to yield similar proportions of hGFP 
positive cells, vector copy numbers (VCN) per cell as calculated by copy 
numbers of WPRE relative to the 2-copy gene mouse telomerase reverse 
transcriptase tert (mtert) at day 5 in P19 cells, proportion of hGFP 
positive cells (hGFP
+
) as assayed by flow cytometry at day 5 in P19 cells 
and ratio of hGFP expressing cells to VCN at day 5. 
promoter MOI VCN/cells at day5 hGFP
+
 cells at day 5 [%] hGFP
+
 cells/VCN at day 5 
CMV 
11 34.5 2.00 1/1725.3 
5 3.2 3.60 1/90.1 
EF-1α 
0.3 0.4 7.80 1/4.9 
0.2 0.2 14.20 1/1.1 
A2UCOE 
0.8 0.3 13.10 1/2.1 
0.3 0.3 15.00 1/1.9 
 
 Long-term expression of hGFP variants in P19 cells using 4.2.2
different promoters 
Flow cytometry analysis of hGFP expression two days after transduction of P19 cells 
with SIN-LVs revealed a similar proportion of hGFP positive cells among all cell lines 
(Figure 22).  
Despite similar proportions of hGFP expressing cells at the start of the 
experiment, the stability of hGFP expression exhibited high variations between 
different promoters and CpG variants over the course of 20 days (Figure 23). hGFP 
expression by the CMV promoter declined rapidly within 5 days (hGFP-0: 12.5 – 2%; 
hGFP-60: 27.4 – 3.6% in 5 days) and remained at this low level thereafter. EF-1α-
driven hGFP expression declined at a slower but constant rate to reach a similar low 
proportion of hGFP positive cells after 20 days (hGFP-0: 18.6 – 1.7%; hGFP-60: 18.7 – 
5.6% in 20 days). In marked contrast, hGFP expression mediated by the A2UCOE 
element clearly increased within 11 days (hGFP-0: 14.3 – 23.5%; hGFP-60: 17 – 27.9% in 
11 days) and fell then progressively back to the initial level of hGFP positive cells. 
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Figure 22 I Flow cytometry histograms of hGFP expression of non-
transduced P19 cells (A) and P19 cells transduced with LVs at day 2 
(B) and day 20 (C) after transduction. Percentage of hGFP positive 
cells [%] is shown in the right corner of each histogram. 
 
Figure S3: FACS histogram of P19 mock control day 2 of the experiment and representative of positive gated 
cells.
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Figure S2: FACS histograms of GFP expression in P19 cells transduced with lentiviruses shown in Figure 1 at  
day 20 after infection.
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Figure S1: FACS histograms of GFP expression in P19 cells transduced with lentiviruses shown in Figure 1 at  
day 2 after infection.
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The MFI of hGFP expressing cells reached the highest levels when transcription was 
controlled by CMV at the start of the experiment. After day 8, expression efficiency 
by CMV decreased to MFI levels lower than transgene expression controlled by the 
EF-1α. The MFI of transgenes driven by A2UCOE revealed slightly lower but very 
constant gene expression levels. For transgene expression controlled by the EF-1α 
promoter, a 2-fold increased MFI was observed for hGFP-60 compared to hGFP-0, 
whereas expression by CMV and A2UCOE was not affected by intragenic CpG 
dinucleotides. To verify the reproducibility of the obtained results, analogous assays 
were conducted with P19 cells transduced at higher MOIs, resulting in an overall 
higher percentage of hGFP positive cells at the start of the experiment but a 
comparable hGFP expression profile for all vectors used in this study (data not 
shown). Thus, the observed effects are irrespective of LV load. 
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Figure 23 I Percentage of hGFP
+
 cells (left panel) and MFI of hGFP
+
 cells (right panel). P19 cells were 
transduced with vectors shown in Figure 21 at different MOIs, shown in Table 7 to yield a similar amount 
of hGFP positive cells measured by flow cytometry. hGFP expression was measured 2 days after 
transduction and subsequently every 3 days up to 20 days, as indicated.  
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Quantitative PCR was performed on day 5 after transduction of P19 cells to determine 
the average vector copy number (VCN) for each of the vector variants. wpre copies 
were compared to the endogenous 2-copy gene mouse telomerase reverse 
transcriptase (mtert). VCNs summarized in Table 7 revealed a similar copy number 
compared to the used MOI (as determined by HEK 293 transduction) for EF-1α and 
UCOE vectors indicating predominance of single copy integrations. In contrast, CMV 
controlled constructs revealed a much higher copy number than the MOI calculated 
from hGFP positive cells by flow cytometry. This result was already anticipated 
considering the high virus concentration applied to reach the hGFP detection limit of 
this gene variant. This is due to the tendency of the CMV promoter to get silenced 
very rapidly immediately after integration, resulting in a lower proportion of hGFP 
expressing cells than hGFP containing cells. Additionally, hGFP-0 tends to confer 
very weak gene expression, which might have led to the sorting of false negative 
hGFP expressing cells. The high ratio of hGFP expressing cells to VCP of EF-1α- and 
UCOE-driven transgenes at day 5 after infection indicated a relatively stable hGFP 
expression compared to CMV-mediated hGFP expression (Table 7). This silencing 
effect is even more pronounced in the CMV hGFP-0 transgene. 
 Partial prevention of hgfp silencing in P19 cells by DNMT 4.2.3
inhibition 
Such severe silencing effects are virtually always connected with DNA methylation, 
which was therefore assumed to be a major contributor of the loss of function in P19 
cells. To test this hypothesis, P19 cells were supplemented with the DNA 
methyltransferase (DNMT) inhibitor 5-Aza-2'-deoxycytidine (5’aza) at day 20 after 
transduction, followed by 2 days of incubation and subsequent flow cytometry 
analysis (Figure 24). An increased proportion of hGFP positive cells was detected 
when grown in the presence of 5’aza, which was associated with an augmented MFI. 
Conversely, the respective cell population containing CMV- and EF-1α constructs 
cultured without 5’aza supplementation led a further repressed state at day 22 after 
infection. UCOE-driven transgene expression stayed continually stable without 5’aza 
treatment and could even be increased up to an average of 20.4% (hGFP-0) and 
27.65% (hGFP-60) upon 5’aza supplementation. The ratio of hGFP expressing cells in 
the presence of 5’aza to their respective control cell group correlated with the extent 
of gene silencing (Table 8). The highest reestablishment of transgene expression was 
observed in CMV hGFP-0, which concordantly also showed the most severe gene 
silencing effects throughout the experiment. The inability of 5’aza treatment to re-
establish initial high levels of hGFP expressing cells is assumed to be due to further 
epigenetic silencing effects, such as histone modifications, which are not affected by 
5’aza. This hypothesis is supported by similar observations in previous transgene 
expression analysis conducted in P19 cells [195]. 
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Figure 24 I hGFP expressing cells of silenced 
hGFP in P19 cells by addition of DNMT inhibitor 
5-Aza-2'-deoxycytidine (5’aza). 5µmol/l 5’aza was 
added to the culture medium to a subset of each 
cell population at day 20 after infection. hGFP 
expression of cells supplemented with and w/o 
5’aza was assayed two days later (day 22 after 
transduction). Bars represent the percentage of 
hGFP
+
 cells, numbers above the bars indicate the 
respective mean MFI of hGFP positive cells. The 
CMV promoter (A), EF-1α promoter (B) and 
A2UCOE elements were compared with regard to 
methylation reversibility. The mean and standard 
deviation of two subsets of cell lines each are 
shown. 
    
 
Table 8 I Ratio of hGFP
+ 
cells supplemented 
with 5’aza to hGFP
+ 
cells without 5’aza at 
day 22. Values were calculated from the ratios 
of of hGFP positive cells in Figure 24. 5’aza 
treatment was carried out for two days. 
 
 
promoter Gene variant 
Ratio of hGFP
+
 cells at d22 
with/ w/o 5’aza 
CMV 
hGFP-0 13.5 
hGFP-60 3.2 
EF-1α 
hGFP-0 4.7 
hGFP-60 1.4 
A2UCOE 
hGFP-0 1.7 
hGFP-60 1.6 
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5  
 Evolution of CpG frequency in the mammalian 5.1
genome 
Due to the degeneration of the genetic code, some nucleotides in the open reading 
frames can be exchanged without changing the resulting amino acid sequence [196]. 
In the wobble position of codons, all thymines can be replaced by cytosines, and 
almost all adenines can be replaced by guanine. Consequently, every gene can be 
encoded by a large number of different sequences. Since the first and second position 
of the codons of almost all amino acids cannot be substituted, the exchange of entire 
dinucleotides would however result in a nonsense mutation. Exceptions to this are 
the dinucleotides ApG, TpC, CpT and CpG. Due to the absent pressure to remain in 
the open reading frames one would assume that the frequency of these dinucleotides 
might decrease compared to other dinucleotides in gene sequences. No evidence can 
however be found in the literature that the ApG, TpC or CpT content is significantly 
different from other dinucleotides within genes of the mammalian genome. In 
marked contrast, genome-wide studies have shown that particularly first exons and 
the 5’region of exons were shown to be rich in CpGs [67][92][93][94]. This is 
particularly striking since CpGs are actually significantly underrepresented 
throughout the mammalian genome as a consequence of their high susceptibility to 
mutation [66]. Despite this negative selection and the absent intragenic pressure, 
evolutionary processes seem to have maintained a high CpG frequency within these 
distinct regions of human genes. It seems obvious that the evolution of this 
intragenic CpG overrepresentation must confer gene expression and its regulation 
any selective advantage over other nucleotide combinations.  
A vast number of studies has been published addressing the role of CpG islands 
and their implication on transcriptional regulation [12][64][89][90][91][95][96][111] 
[197][198]. These stretches of mostly unmethylated CpGs are predominantly found 
within the promoter and the first exon of several genes, particularly housekeeping 
genes [67][89]. CpG islands have long been known as transcriptional promoting 
elements [91]. Apart from CpG islands, which compose only 1-2% of the vertebrate 
genome [199], most of the CpG dinucleotides in the mammalian genome are 
methylated. The majority of methylated DNA in normal adult tissue is harbored by 
non-coding transposable elements such as SINEs, LINEs and endogenous retroviruses 
[80][81]. DNA methylation within these non-functional stretches of the genome 
function to maintain the repressed chromatin state and therefore stably silence 
promoter activity [200]. 
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 CpG dinucleotide usage is pivotal for transgene 5.2
expression 
Depending on the origin, their genomic surrounding, developmental stage and type 
of the cell, CpG dinucleotides can have opposing effects on gene expression efficiency 
(see chapter 3.4). Thus, CpG dinucleotides should be used with caution in gene 
design for applications such as gene therapy or the production of recombinant 
proteins in mammalian cells.  
Several studies have reported that CpG depletion from transgenes improves the 
persistence of expression in host cells [201][202][203]. In vivo studies in transgenic 
mice using a CpG containing reporter gene have shown that methylation of the 
upstream EF-1α promoter is induced resulting in transcriptional gene silencing, 
whereas the CpG-depleted reporter had no influence on promoter methylation and 
led to an extended reporter activity [204]. CpG-containing transgenes were even 
reported to diminish the expression of an adjacent reporter gene located on the same 
plasmid, while the CpG-depleted equivalent transgene had no negative effect on 
reporter expression [205]. These observations led to the accepted theory that CpG 
dinucleotides should be avoided when designing transgene expression vectors. In 
contrast, CpGs within genes have also been found to be beneficial for expression 
levels, such as by improving RNA stability [206]. Previous studies in our laboratory 
have shown that the depletion of CpGs from different transgenes such as hGFP [172], 
the capsid protein of HIV and murine erythropoietin (mEPO) [162] resulted in a 
drastic loss of reporter activity in mammalian cell lines and mice, respectively. 
Conversely, intragenic CpG enrichment clearly enhanced gene expression of the 
reporter mMIP-1α in H1299, CHO and HEK 293 cells [170]. It was demonstrated that 
intragenic CpG dinucleotides positively correlate with altered de novo mRNA 
synthesis [162][170][172].  
 Intragenic CpG abundance determines expression 5.3
levels of hGFP and mMIP-1α 
The reporter genes hgfp and mmip-1α used in previous CpG studies served as basis for 
experimental analyses of CpG-mediated epigenetic regulation mechanisms in the 
thesis at hand. mmip-1α and hgfp genes were previously modified with regard to 
optimal codon usage according to the CAI [160] and their intragenic CpG content. 
Humanized GFP (hGFP-60) [171], harboring 60CpG in its ORF, was used as the basis 
for the generation of the CpG-lacking hGFP-0 [169]. The wild type mmip-1α gene 
sequence was subjected to computer-assisted optimization strategies with initial 
focus on codon usage (mMIP-13). Based on mMIP-13, intragenic CpG dinucleotides 
were depleted (mMIP-0) and maximized (mMIP-42), respectively [170]. In 
accordance with previous data obtained for hGFP and mMIP-1α, expression analysis 
of both transiently transfected H1299/HEK 293 cells [170] as well as of stably 
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transfected CHO Flp-In (hGFP)/ HEK 293 (mMIP-1α ) cells could verify the positive 
correlation between intragenic CpG content and transcription efficiency. Notably, 
changes in protein levels between CpG variants were even more pronounced in stably 
transfected cells compared to transient transfected cells (data not shown). This 
already implies that chromatin dynamics or epigenetic marks in the proximity of the 
transgene affect its transcription regulation in a CpG-dependent manner. 
The CpG depletion in hgfp resulted in a CAI of 0.93, which is insignificantly lower 
than that of hGFP-60 (0.96). These minor differences in CAI are unlikely to result in 
the 6-fold increase in protein levels of stably expressed hGFP-60 compared to hGFP-0 
(CHO Flp-In cells; Figure 9). The applied sequence modifications in mmip-1α resulted 
in a high CAI for the codon optimized (mMIP-13) and the CpG-depleted (mMIP-0) 
cytokine variants, but a CAI below wild type (mMIP-wt) for the CpG-maximized 
(mMIP-42) cytokine variant. Despite low CAI, mMIP-42 showed the highest 
expression levels (5-fold in stable HEK 293 Flp-In cells compared to mMIP-wt), while 
mMIP-0 gave protein yields barely above the detection limit despite a higher CAI 
than mMIP-wt and mMIP-42 (Figure 9). Adapting the codon usage usually results in 
increased expression yields [158], which could not be observed for mMIP-13 in the 
given experimental setting. Since gene-optimization was not the object of the study 
at hand, this correlation was not further scrutinized. In order clarify the effects of 
codon optimization on gene expression, these analyses will be repeated. 
Nevertheless, according to the 5-fold increased protein levels upon 
CpG maximization, gene optimization of hgfp and mmip-1α with regard to codon 
usage can be excluded to be the crucial modification promoting gene expression in a 
CpG-dependent manner.    
It was shown that short half-lives observed for transiently expressed genes, such 
as lymphokines, cytokines and transcription factors, correlate with the presence of 
AU-rich elements in their 3’UTR [207]. UpA-dinucleotides are preferred targets of 
endoribonuclease cleavage which results in decreased mRNA stability [206]. It is 
therefore tempting to argue that increasing the CpG content simultaneously 
decreased the TpA and AU content, respectively, thereby increasing mRNA stability. 
During the modification process of hgfp and mmip-1α however, TpA amounts were 
not changed significantly (Table 3).  
Another study found a correlation of high mRNA levels and increased GC 
frequency [208]. This raises the question whether an increased GC rate might actually 
be responsible for the effects ascribed to CpG dinucleotides in this study. This 
possibility can also be excluded, since the overall GC content among transgene 
variants was barely changed, and the observed changes in protein yields do not 
generally correlate with GC content (Table 3; Figure 9). In addition to similar GC and 
TpA frequencies, care was taken during the modification process to not create any 
TATA-boxes, cryptic splice sites, internal polyadenylation sites or other regulatory 
elements. In search of the responsible mechanism for the observed phenotypes, 
altered gene expression was proven to be irrespective of biased transfection rates, 
translation efficiencies, mRNA export and splicing activities. Instead, it was shown 
that intragenic CpG dinucleotides lead to increased gene transcription. 
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CpG-dependent effects were verified with different mammalian cell lines and various 
promoters [162][170][172].  
 Intragenic CpG dinucleotides confer no disadvantage 5.4
for long-term expression in mammalian Flp-In cells 
Effective and sustainable transgene expression in mammalian cells is a major aspect 
in the production of recombinant protein [179]. Once a transgene is stably integrated 
into the host cell, it is affected by the genomic DNA surrounding the integration 
locus. Especially epigenetic marks spreading their repressive modifications to the 
proximal transgene are a crucial issue [124]. Another problem leading to reduced 
expression sustainability is the loss of the transgene over time due to the outgrowth 
of a less productive, metabolically favored sub-population, or the ejection of the 
complete transgene via its recombination site [209]. Hence, the production of 
recombinant proteins usually requires some kind of selection pressure in order to 
maintain sustainability of transgene expression. 
Transgenes stably integrated into mammalian cells via the Flp-In recombination 
system served for comparative analysis of CpG-associated epigenetic mechanisms. 
The Flp-In system was chosen as it ensures stable insertion of a single copy of the 
transgene at a specific location within an active chromatinized setting [165]. All 
plasmids used for transgene delivery into mammalian Flp-In cells contained a 
hygromycin resistance gene (hph) which was stably integrated into the cells together 
with the transgene. To maintain selective conditions, hygromycin was added to the 
culture medium. hph, which was located in the proximity of the transgene-driving 
promoter, therefore had to be constantly expressed. The transgenes integration into a 
transcriptionally active genomic region, and also the constant and high transcription 
of the upstream hph gene have important functions; first of all, these features provide 
a selective advantage for cells carrying the transgenes, and secondly, they keep the 
chromatin structure at the promoter and ORF permissively open and the DNA 
unmethylated. There are, however, utilities for recombinant protein production that 
need cells to grow under antibiotic-free conditions, such as to minimize cellular 
stress [210] or to avoid the contamination of cells with antibiotics in industrial 
fermentation processes [211].  
It was hypothesized that intragenic CpG dinucleotides might negatively affect 
expression levels upon selection pressure withdrawal due to methylation of 
intragenic CpG dinucleotides and chromatin compaction. To address this issue, CHO 
Flp-In cells stably transfected with hgfp variants were cultivated either with or 
without selection pressure over the course of one year. Both the CMV and the EF-1α 
promoter were examined for their ability to confer stable transgene expression. 
While selective conditions preserved 100% hGFP expressing cells, the withdrawal 
of selection pressure resulted in gradually decreasing ratios of hGFP positive cells 
(Figure 10, Table 4). Surprisingly, intragenic CpG dinucleotides did, however, not lead 
to accelerated gene expression loss compared to CpG-lacking gene variants. Instead, 
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the reduction of hGFP-0 expressing cells occurred even slightly faster compared to 
hGFP-60, irrespective of the used promoter. The efficiency of hGFP expression 
(quantified as MFI) on the other hand decreased both in the absence and in the 
presence of selection pressure. In CMV driven constructs, the decrease occurred 
faster in cell lines expressing hGFP-60 compared to cells harbouring hGFP-0. 
Contrary and most notably, hgfp transcription driven by the EF-1α promoter could 
resist gene silencing more effectively with an increased intragenic CpG content. The 
results imply that selection pressure at least fulfilled one purpose – the prevention of 
transgene ejection or the outgrowth of transgene lacking cells. This was achieved for 
both CpG variants and for both promoters analyzed. Upon selection pressure 
withdrawal however, the ratio of hGFP positive cells of all gene variants and 
promoters decreased gradually. To distinguish whether this effect was a consequence 
of transgene loss or epigenetic downregulation, cells maintained without selection 
pressure were sorted into subpopulations according to their expression level, 
followed by detailed transgene analysis.  
 Intragenic CpG dinucleotides cause increased 5.5
DNA methylation rates, whereas low CpG content 
promotes transgene loss  
CHO Flp-In cells stably expressing hGFP variants and maintained without selection 
pressure were sorted into the subpopulations maximal (max), moderate (mod) and 
no expression. Quantitative PCR of isolated DNA of the respective cell populations 
could show that absent (no) hGFP expression coincided with a decreased relative 
copy number compared to moderately and highly expressing cells. The transgene loss 
was almost 2-fold higher in hGFP-0 compared to hGFP-60 (Figure 12). To elucidate to 
what extent the decreasing hGFP expression efficiency arouse from DNA 
methylation, bisulfite sequencing of genomic DNA isolated from respective 
subpopulations was carried out. Evaluation of the according chromatograms revealed 
that selection pressure could not only eliminate the risk of transgene loss, but also 
prevent from DNA methylation. Withdrawal of selective conditions, on the other 
hand, resulted in increased levels of methylation (Figure 13). The methylation level of 
transgenes clearly correlated with expression efficiency in both hGFP-0 and hGFP-60. 
hGFP-0 lacks methylation targets in the ORF, whereas hGFP-60 provides many 
potential sites for de novo methylation. De novo DNA methyltransferases (DNMTs) 
have the tendency to spread bidirectional in the genome [212]. Hence, it is assumed 
that the excessive amount of intragenic CpG dinucleotides in hGFP-60 attracts many 
de novo DNMTs, leading to ORF methylation, which then spreads to the promoter 
and reinforces the silencing effect. This hypothesis is further supported by the 
finding of an increased methylation level of the ORF in transcription start site (TSS) 
proximity, which gradually decreases towards the 3’end. This methylation gradient 
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also implies a greater regulatory function of CpG dinucleotides in the 5’intragenic 
region compared to downstream loci.  
Considering the inverse rates of DNA methylation and transgene ejection 
between hgfp variants (Table 5), it seems obvious that the reduced methylation 
targets of hGFP-0 compared to hGFP-60 were compensated by an increased 
frequency of complete transgene loss.  
Cell lines cultivated under selective conditions neither showed any signs of 
transgene loss, nor DNA methylation. Yet, the transcription efficiency slowly 
decreased over the period of one year (CMV-hGFP-0 41%; CMV hGFP-60 46%; 
Table 4). This decline of expression efficiency was already observed in previous 
experiments in our laboratory with the reporter mMIP-1α. By the supplementation of 
sodium butyrate (NaB), which is an inhibitor of histone deacetylases (HDACs), this 
expression decline could partly be reversed [186]. HDACs remove acetyl groups from 
histones and thereby contribute to gene repression [44].  
Altogether, these results indicate that transcription of CpG variants is regulated 
by several epigenetic processes working in concert to control transgene expression.    
 Intragenic CpG dinucleotides alter chromatin 5.6
structure  
Transcriptional activity is affected by chromatin structure and vice versa. Histone 
modifications, histone variants, chromatin remodeling and the DNA sequence itself 
impact on transcriptional events (see chapter 3.3). It was thus interesting to evaluate 
in what respect differential transcription rates observed upon intragenic 
CpG variations were reflected by chromatin changes. 
 Chromatin density of hgfp transgenes is affected by 5.6.1
intragenic CpG dinucleotides and growth conditions in vivo 
To examine the chromatin density of CpG variants in vivo, genomic DNA of CHO 
Flp-In cells expressing hGFP variants was subjected to FAIRE. Cell populations 
cultivated either with or without selection pressure were analyzed. Out of the cell 
population cultivated without selection pressure, only the fraction in which hGFP 
expression was no longer detectable (denoted as “no expression”) was examined. 
The amount of extracted nucleosome-free DNA isolated from the TSS and ORF of 
hgfp clearly correlated with the presence of selection pressure. Thus, withdrawal of 
selective conditions not only induced DNA methylation but also a clearly increased 
chromatin density at the TSS of hGFP-0 and hGFP-60.  
It is well established that processes involving DNA methylation and (modified) 
histones are tightly connected [49]. An example of proteins connecting histone and 
DNA modification is DNMT3L, which assists the binding of 
de novo methyltransferases to DNA (see chapter 3.3.1). Once H3K4 loses its 
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methylation, the DNMT-DNMT3L complex can bind to DNA and methylates CpG 
dinucleotides [117][49]. Inversely, histone methyltransferases have been found to 
recruit de novo DNA-methyltransferases, thereby silencing gene expression [50]. The 
crosstalk between DNA methylation and histone modification or chromatin 
compaction can go in both directions. DNA methylation and chromatin 
condensation in hGFP expressing cells are supposed to have affected each other. The 
direction of causality and the identification of histone modifications involved in the 
silencing process could however not be determined by this experiment.   
Quantitative comparison of isolated nucleosome-free DNA of hGFP-0 and 
hGFP-60 stably expressed by cells under selective conditions revealed another 
striking aspect. hGFP-0 lacking intragenic CpGs showed a significantly higher 
chromatin density at the ORF compared to hGFP-60 (Figure 14). It is assumed that 
the increased chromatin density resulting from intragenic CpG depletion is a major 
contributor of impeded transcription efficiency. Changed chromatin density of hgfp 
variants was clearly visible in CHO Flp-In cells cultivated under selection pressure, 
but was not observed in CHO Flp-In cells cultured without antibiotic selection. It 
seems that the effect of nucleosome reorganization resulting from CpG variations is 
lost upon selection pressure removal in favor of a more intensive chromatin 
condensation. Altogether, these results imply that chromatin structure plays a crucial 
role in the CpG-mediated transcription regulation.  
 Chromatin density of mmip-1α transgenes is increased upon 5.6.2
CpG depletion in vivo 
 
To verify that CpG depletion leads to a chromatin condensation also for a different 
reporter gene and cell line, FAIRE was analogously carried out to analyze the 
chromatin density of HEK 293 Flp-In cells stably expressing the mMIP-1α variants at 
the TSS and the 3’UTR under selection pressure. The results revealed similar levels of 
nucleosome density between mMIP-wt, mMIP-13 and mMIP-42. In contrast, mMIP-0 
exhibited a significantly higher degree of chromatinization, both at the TSS and the 
3’UTR (Figure 15). These results are in concordance with hGFP FAIRE analysis and 
confirm that CpG depletion leads to local condensation of chromatin. This 
conclusion is further supported by a study of nucleosome remodeling in mammalian 
primary response genes by Toll-like receptors that has revealed a tendency of CpG 
islands to exhibit a reduced nucleosome occupancy as a direct result of their 
nucleotide content [213]. CpG maximization, however, did not lead inversely to 
further chromatin de-compaction. The missing correlation of chromatin density and 
expression efficiency for mMIP-42 can be explained by the features of the Flp-In cell 
system. This system mediates transgene integration within a transcriptionally 
accessible chromatin conformation [165]. Taking this into account, the 
CpG enrichment in mMIP-42 presumably did not lead to further disaggregation of 
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chromatin in vivo due to saturation effects of the already very open chromatin 
structure at the Flp-In recombination locus.  
The relative differences of chromatin densities among CpG variants could not be 
observed in H3 and H3K4me3 ChIP analyses (Figure 16). It is assumed that DNA 
fragments generated by sonication in the ChIP procedure were too large to clarify the 
local differences of histone occupation on the small mmip-1α gene and the promoter. 
Furthermore, H3K4me3 is a histone modification usually associated with the 
promoters of active genes (see chapter 3.3.1) [39]. The presence of H3K4me3 in all 
gene variants irrespective of intragenic CpG content reflects that the genes are 
generally located in a transcriptionally active locus. It is assumed that this active 
surrounding and the promoter itself are responsible for the recruitment of H3K4me3.  
This histone modification is therefore unlikely to explain the severe changes in 
transcription efficiency. Further gene activating histone modifications, particularly 
those coinciding with gene bodies such as H3K9me1, H3K27me1 or H3K36me (see 
chapter 3.3.1) [39] should be of great interest in future experiments to identify the 
responsible CpG-triggered control mechanisms.       
 CpG dinucleotides in hgfp affect nucleosome positioning 5.6.3
abilities in vitro 
The differences of chromatin compaction in correlation to intragenic CpG changes 
led to the assumption that also the nucleosome positioning abilities might be 
affected by CpG changes. In vitro nucleosome reconstitutions with PCR fragments of 
hgfp variants were assembled by salt dialysis. The comparison of the nucleosome 
position pattern indeed revealed individual positioning capabilities among hgfp 
variants in vitro (Figure 18). Altered nucleosome positions as a result of CpG 
variations could previously be shown for the reporter gene mmip-1α [186]. 
Nucleosome preferences in vitro originate from the sequence-dependent 
mechanics of the wrapped DNA itself [214]. Early studies postulated that intrinsic 
DNA sequence preferences also affect nucleosome positioning in vivo [58][215]. 
Subsequent analyses demonstrated that in vitro nucleosome preferences indeed often 
reflect in vivo locations [216][217] and that nucleosome positioning in vivo can be 
predicted based on the genomic DNA sequence alone [218]. According to a genome-
wide analysis of nucleosome positioning, approximately 50% of the in vivo 
nucleosome organization is solely determined by sequence preferences of 
nucleosome occupation [59]. The in vivo nucleosome occupancy map of 
human mip-1α (hmip-1α) reveals a strong positioning preference of the +1 nucleosome 
at the 5’ end of the coding sequence of hmip-1α that is shifted 40 nucleotides 
upstream when activated upon inflammation (unpublished data; group of Prof. 
Längst, Regensburg). Assuming that the mmip-1α transgene model used in this study 
is comparable to the endogenous situation, it is concluded that the positioning 
abilities of the +1 nucleosome plays an important role in the observed transcriptional 
changes of transgenes.  
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Considering the sum of chromatin analyses, it is hypothesized that differential 
transcription efficiencies of CpG variants result from the creation of a 
transcriptionally more, respectively less, favorable nucleosome arrangement 
facilitated by intragenic CpG dinucleotides. More precisely, altered gene 
transcription efficiency is supposed to result from a combinational effect of changed 
nucleosome positioning and chromatin density.  
 Intragenic CpG dinucleotides increase transcription 5.7
elongation of mmip-1α 
FAIRE analyses in this work could elaborately show that the Flp-In system targets the 
transgenes into an active genomic environment. This transcriptionally active setting 
of the transgene Flp-In locus was furthermore reflected by the abundance of total 
and engaged RNAPII at the promoter of all mmip- 1α variants compared to gapdh, as 
quantified by ChIP analysis. Similar RNAPII binding to the promoter between the 
gene variants indicated that RNAPII recruitment is not modulated by CpG 
dinucleotides downstream (Figure 19). In fact, genome-wide studies of transcription 
regulation in human cells have demonstrated that approximately 20% of unexpressed 
genes are constantly occupied by preloaded RNAPII prior to transcription initiation 
[219]. Phosphorylation of serine-2 (Ser2P) at the carboxy-terminal domain (CTD) of 
RNAPII is a modification that occurs later in the transcription cycle during the 
elongation process [19]. Among all mmip-1α variants, an equal amount of Ser2P 
RNAPII at their promoters was found. Upstream Ser2P RNAPII density therefore also 
excludes abortive transcription initiation to be responsible for CpG-divergent 
transcription rates. However, a trend of an increased amount of actively transcribing 
RNAPII at the 3’UTR of mMIP-42 compared to mMIP-wt, mMIP-13 and mMIP-42 
could be detected. The synthetic mmip-1α used in this study contains no introns and 
hence is a small gene of 279bp, which is too short to be occupied by more than one 
Polymerase simultaneously. Determining the efficiency of transcriptional elongation 
as de novo mRNA transcripts per unit density of elongating Pol II, it is concluded that 
RNAPII molecules traverse the ORF of mMIP-42 at a higher elongation rate than of 
mMIP-wt, mMIP-13 and mMIP-0. 
 Gene expression benefits from TSS-proximity of 5.8
intragenic CpG dinucleotides  
The ability of CpG dinucleotides to enhance elongation rates led to the question 
whether a specific region within the ORF of CpG variants was responsible for this 
effect. Thus, gene chimeras with CpG clusters in distinct intragenic 5’ and 3’ regions 
of the ORF were generated. Analyses of CHO Flp-In cells stably expressing hGFP 
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chimera, containing CpG clusters in either 5’ or 3’ regions of the ORF, showed that 
not only the amount of CpG dinucleotides, but particularly the localization of CpG 
dinucleotides in proximity to the start codon, respectively TSS, is pivotal for efficient 
gene transcription (Figure 20).  
Interestingly, genome-wide studies of regulatory regions in the human genome 
have shown that the average of protein coding genes in the human genome display a 
significant excess of CpG dinucleotides in the 5’ ends of exons, most pronounced in 
the first exon [67][92][93][94]. In a genome-wide transcriptome analysis of different 
human cell lines, a positive correlation of expression efficiency and CpG frequency at 
the TSS +500bp downstream was found (unpublished data; cooperation with group of 
Prof. Längst, Regensburg). CpG frequency in the gene body was low in both gene 
sets. CpG dinucleotides are depleted throughout the mammalian genome as a 
consequence of their high susceptibility to mutation [66]. Despite this negative 
selection, evolutionary processes apparently seem to have maintained a high CpG 
frequency at the TSS-proximity in a group of genes in correlation to their expression 
performance. A genome-wide study by Choi et al. investigated the nucleosome 
deposition and DNA methylation at regulatory regions in human cells. The authors 
have likewise revealed a group of genes with exceptionally high frequency of mainly 
unmethylated CpGs at the 5’ gene end [220]. These genes were furthermore found to 
exhibit high expression rates compared to average expression levels, and even higher 
than in genes controlled by a promoter CpG island. The authors ascribe the enhanced 
expression levels to effects of elongation control. These data obtained by previous 
investigations and the findings described in the study at hand point to the very 
important function of intragenic CpGs proximal the intragenic 5’ region. In the case 
of hgfp and mmip-1α transgenes, 5’-adjacent CpGs seem to play a major role in the 
configuration of chromatin architecture, allowing efficient transcription elongation.  
 CpG frequency and type of promoter determines 5.9
transgene stability in pluripotent stem cells P19 
CHO Flp-In cells demonstrated gradually decreased transgene expression over the 
period of one year without selection pressure (4.1). The gene expression decline 
correlated with transgene loss, DNA methylation and a higher degree of 
chromatinization in vivo. Despite these repressive events, transgene expression was 
still clearly detectable in a surprisingly high percentage of cells at the end point of the 
experiment. The Flp-In cell system used in this study provided site-specific single 
copy integration of the respective transgenes within a transcriptionally active and 
epigenetically constant genomic environment under standardized conditions. Due to 
these abilities, the Flp-In system was the tool of choice to compare regulation 
mechanisms responsible for differential transcription efficiencies between CpG‐
variants. On the other hand, the consistent transgene integration into one specific 
genomic locus might restrict CpG-mediated mechanisms to a limited spectrum of 
epigenetic regulation. Moreover, the Flp-In system does not represent a relevant 
Discussion 
Page | 70  
 
technique for gene therapy applications, the optimization of which is one of the long-
term goals of this project. Instead, retro- and lentiviral vectors are frequently applied 
in gene therapy trials [187][188][189]. The mammalian Flp-In cells used for 
comparative expression analyses were exclusively differentiated cells. However, not 
differentiated somatic cells, but rather stem cells are the major source for 
regenerative medicine [190][191][192]. Embryonic stem (ES) cells have a much higher 
potential of de novo methylation [221] and epigenetic control in general [193] than 
differentiated somatic cells. Thus, expression sustainability by different regulatory 
transgene elements in ES cells has to be elaborately tested prior to their application. 
LVs have a preference for integration into the proximity of active transcription 
units [130]. However, the integration location is not directed to one identical region 
in all cells, as in the Flp-In system. Particularly the development of self-inactivating 
retroviral vectors (SIN LVs) with a deleted U3 region of the 3’LTR containing the viral 
enhancer sequence provides gene transfer with higher safety due to the reduced risk 
of enhancer-mediated mutagenesis [131][222]. SIN-LVs incorporating respective 
expression cassettes were used to introduce hgfp variants of different intragenic CpG 
content into P19 cells. P19 embryonic carcinoma cells are pluripotent stem cells with 
the ability to differentiate into various cell types such as neuronal, glial, cardiac and 
skeletal muscle [223][224]. The ability to change their phenotype completely arises 
from their immense potential of epigenetic regulation [225]. This feature was utilized 
to challenge transgene stability. P19 cells were transduced with SIN-LVs 
incorporating hgfp transgenes containing a different CpG content to investigate the 
susceptibility of this reporter gene to be silenced dependent on intragenic 
CpG frequency. Further to that, the stability of transgene expression from different 
promoters was tested. The CMV promoter, the human EF-1α and the A2UCOE 
element from the human HNRPA2B1-CBX3 locus were compared regarding their 
capacity to mediate stable transgene expression.  
 CMV- and EF-1α-promoter-mediated hGFP expression is 5.9.1
gradually silenced in P19 cells  
Despite similar infection rates at the start of the experiment, the stability of hGFP 
expression revealed substantial differences depending on the driving promoter 
(Figure 23).  
The CMV promoter is widely used due to its strong gene expression potential in 
several tissues [226][227]. This feature was elaborately verified in this study by all 
experiments conducted in Flp-In cells. The CMV promoter is however also known to 
confer very variable expression depending on the cell type [228], which seems most 
critical in ES cells [229][230]. Indeed, the disposition to undergo extensive epigenetic 
repression in ES cells became already apparent at the start of the experiment, 
reflected by the requirement of a very high MOI for the transduction of P19 cells to 
reach the hGFP detection limit (Table 7). Progressing silencing forces became 
increasingly obvious through the rapid decline in hGFP expression immediately after 
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gene transduction albeit multiple transgene copies. These characteristics of a high 
silencing activity of CMV controlled transgenes were even more pronounced in 
hGFP-0. Thus, a decreased intragenic CpG content was not able to prevent gene 
silencing, which is a widely used strategy in transgene expression applications 
[161][201][202]. Instead, the generally low potential of CpG-lacking transgene 
expression seems to even promote the rapid silencing of CMV- controlled hGFP 
expression. Despite the ability of hGFP-60 to induce a higher expression rate at the 
start of the experiment (as quantified by the MFI), gene silencing led to a decreased 
MFI similar to hGFP-0 after just five days.  
The human EF-1α promoter is a widely used element to regulate retroviral 
transgene expression claiming robust and constitutive gene expression[228][231]. 
According to a low required MOI to reach detectable hGFP signals and the 
observation of a low vector copy number (VCN) when transduced at a low MOI, the 
EF-1α promoter indeed appeared to be a more suitable regulating element compared 
to the CMV promoter. Nevertheless, also EF-1α-mediated transgene expression 
declined gradually over the period of 20 days. Interestingly, the EF-1α-controlled 
expression level of hGFP (as quantified as MFI) in P19 was increased by 2-fold in 
hGFP-60 compared to hGFP-0. Consistent with CMV-promoter vectors, EF-1α 
promoter-mediated hGFP expression therefore seems to benefit from intragenic CpG 
content, leading to a delayed gene repression. Despite the delayed silencing effects of 
the EF-1α compared to the CMV promoter, the amount of hGFP expression was still 
almost completely diminished after 20 days. This also makes the EF-1α promoter 
appear to confer insufficiently stable gene expression for ES cell applications.  
 A2UCOE confers stable hGFP expression in P19 cells and 5.9.2
prevents hGFP repression upon intragenic CpG depletion 
Several cis-elements have been proposed to avoid transgene silencing, such as locus 
control regions (LCRs), chromatin insulators or scaffold/matrix attachment regions 
(S/MARs) [232]. Further to these elements, ubiquitous chromatin opening elements 
(UCOEs) consisting of divergently transcribed promoters of housekeeping genes, 
surrounded by a methylation free CpG island with a chromatin opening ability, were 
demonstrated to induce stable transgene expression. UCOE derived from the human 
HNRPA2B1-CBX3 locus (A2UCOE) was shown to confer stable levels of transgene 
expression in a variety of different cell lines, including P19 cells [195][233]. Due to 
these observations, A2UCOE was included in the expression analyses of this study to 
test the impact of these chromatin modifying features on hGFP expression with 
respect to varying intragenic CpG content. Indeed, the number of hGFP expressing 
cells as well as the MFI of hGFP-0 and hGFP-60 remained constant during the period 
of the experiment. Moreover, a high ratio of hGFP positive cells to VCN was 
observed. This indicates a high proportion of actively hGFP expressing cells and a low 
silencing tendency. Remarkably, gene expression was equally efficient between 
hGFP-0 and hGFP-60, as reflected by an equal and constant MFI.    
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Flp-In expression analyses demonstrated that the lack of intragenic CpGs in hgfp led 
to decreased transcription efficiency and that this effect can at least in part be 
ascribed to a transcriptionally more unfavorable chromatin structure and 
nucleosome position. A2UCOE can provide a transcriptionally active environment 
through its chromatin opening features. It is assumed that the methylation-free CpG 
islands of A2UCOE interact with active histone modifications and that the 
bidirectional transcription by the UCOE closely spaced dual divergent promoters is 
associated with an inherent chromatin opening function [195]. Based on these 
observations and in concordance with the findings of this study, the chromatin 
opening features of A2UCOE seem to overcome the establishment of a more 
repressive chromatin state induced by the lack of CpG dinucleotides. 
 DNMT inhibition partly prevents hgfp silencing in P19 cells 5.9.3
depending on promoter usage 
Previous studies elaborately demonstrated a clear correlation of DNA methylation 
and declined transgene expression in P19 embryonic carcinoma cells [195]. The spleen 
focus-forming virus (SFFV) LTR exhibited an almost complete state of CpG 
methylation, EF-1α was methylated to a significantly lower degree compared to SFFV, 
whereas the UCOE element showed only very weak levels of methylation. In the light 
of these findings and in concordance with the observations described above, DNA 
methylation was assumed to be a major contributor to the loss of function in P19 
cells. Detailed methylation levels of hgfp-transduced P19 cells were not elaborately 
examined within the scope of this work. However, a contribution of 
DNA methylation events on hgfp repression was investigated by application of the 
DNA methyltransferase (DNMT) inhibitor 5-Aza-2'-deoxycytidine (5’aza) to P19 cells 
stably integrated with the respective gene variants. Indeed, the ratio of hGFP positive 
cells grown in the presence of the 5’aza correlated with the extent of gene silencing. 
The highest re-establishment of silenced transgenes was observed in CMV hGFP-0, 
whereas A2UCOE-driven transgenes were almost not affected by the de-methylating 
agent (Figure24; Table8). The inability of 5’aza treatment to re-establish initial high 
levels of hGFP expressing cells is assumed to be due to further epigenetic silencing 
effects, such as histone modifications, which are not affected by 5’aza. This 
hypothesis is supported by similar observations in previous transgene expression 
analyses conducted in P19 cells [195]. 
 
The data clearly demonstrated that the stability of transgene expression in SIN 
LV-transduced P19 carcinoma stem cells depend on the choice of promoter and 
transgene sequence. The strong viral CMV is unsuitable due to its high potential to 
become silenced. The EF-1α promoter is silenced as well, albeit at a lower rate. 
Furthermore, transgene expression from EF-1α benefits from an augmented 
intragenic CpG frequency, reflected by delayed silencing effects and a two-fold 
increase in expression efficiency up to at least 20 days after transduction. In contrast, 
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CpG accumulation seemed to have no positive effect on A2UCOE-driven transgenes, 
as this element itself induces a permissive chromatin state.    
 Proposed CpG-mediated transcriptional control 5.10
mechanism and outlook 
Considering the sum of observations obtained from hGFP and mMIP-1α analyses in 
the study at hand, the following scenario is proposed: CpG differences within the 
ORF of hgfp and mmip-1α cause an altered arrangement of nucleosomes. Intragenic 
CpG depletion results in a more compact chromatin structure, thereby impeding 
effective transcription elongation. By contrast, the accumulation of CpG 
dinucleotides induces nucleosome rearrangement and instability. It is suggested that 
particularly the removal of the +1 nucleosome from the start codon facilitates 
effective transgene elongation. Similar conclusions were drawn by independent 
investigations. Choi et al have suggested that the deposition of nucleosomes 
downstream of the TSS by CpGs and their modification plays a pivotal role in 
epigenetic regulation [220]. In a Review, Harinder Singh described CpG islands as the 
“transcriptional tee off areas of the mammalian genome that provide a nucleosome-
depleted surface“ for efficient transcription elongation [12]. Support of this 
hypothesis is further provided by a study of mammalian primary response genes by 
Toll-like receptors, in which the authors claim CpG-island promoters to facilitate 
“promiscuous induction from constitutively active chromatin without a requirement 
for […] nucleosome remodeling complexes” [213]. It is assumed that intragenic CpGs 
in mMIP-42 and hGFP-60 mimic CpG islands and thereby exhibit CpG-island typical 
features.  
One consequence of the weakened chromatin structure facilitated by CpGs is 
the greater accessibility of the underlying DNA to transcriptional regulators in vivo. 
Several transcription factors have been found to affect transcriptional elongation. 
The DRB sensitivity-inducing factor (DSIF) and the negative elongation factor 
(NELF) are known to induce transcriptional pausing. By contrast, the transcription 
factor IIF (TFIIF), protein kinase P-TEFb and the eleven-nineteen lysine-rich in 
leukemia (ELL) activate efficient elongation. A detailed overview of Pol II elongation 
factors is reviewed in [234]. Trans-activating factors directly associated with 
unmethylated CpG dinucleotides might also contribute to the observed phenotype. 
The ubiquitously expressed CXXC finger protein 1 (CFP1) specifically and exclusively 
binds unmethylated CpG dinucleotides, thereby trans-activating transcription [235]. 
CFP1 is discussed to play an important role as an epigenetic regulator in modulating 
gene expression via CpG dinucleotides [236]. Both the overexpression and 
downregulation of CFP-1 in 293 Flp-In cells stably expressing mMIP-1α did however 
not show significant changes in mMIP-1α expression levels (data not shown). KDM2A 
is another factor binding to CpG dinucleotides. It removes H3K36 methylation, 
thereby creating a “CpG island chromatin” that is depleted of this repressive 
modification [110]. It is very likely that there exist several more transcription factors 
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not identified so far, representing probable candidates for CpG-based effectors of 
transcription enhancement. Complex epigenetic processes can be triggered by CpG 
dinucleotides (see chapter 3.4.3). Looking at the ever increasing number of 
discovered epigenetic regulation mechanisms, a substantial impact of CpG 
dinucleotides on transcription regulation becomes apparent. Occupation of the 
histone modification H3K4me3, which is often found in CpG islands [107][237] was 
not significantly changed between the CpG variants of mMIP-1α. However, looking at 
the wide range of histone modifications associated with gene regulation, it is very 
likely to discover histone modifications, remodeler or histone variants that act in 
concert to generate the observed CpG-mediated differences in expression efficiencies 
in the near future. The identification of such regulators and responsible DNA 
sequence elements will provide new perspectives regarding CpG-rich transgenes 
designed for efficient expression in mammalian cells.   
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6  
 Cell lines  6.1
Cell type Origin Comments ATTC no. 
HEK 293T/17 Homo sapiens 
Ad5 transformed embryonic kidney 
cells  
CRL-11268 
HEK 293 Flp-In Homo sapiens 
HEK 293 cells with a single stably 
integrated FRT site (Invitrogen R750-
07) 
CRL-1573 
CHO Flp-In 
Cricetulus 
griseus 
Based on Chinese hamster ovary cells 
CHO-K1 (Invitrogen R758-07) 
CCL-61 
P19 Mus musculus 
Derived from an embryonal 
carcinoma induced in a C3H/He mouse 
CRL-1825 
 Bacterial strains 6.2
Bacterial strain Description 
DH5α f- supE44 ΔlacU169 (φ80 lacZΔM15) hsdR1 recA1 endA1 gyrA96 thi1 relA1 
 Media and supplements 6.3
Medium Composition Supplements Organism  
LB0 (Luria Bertani) 
1% Bacto-tryptone 
0.5% yeast extract 
1% NaCl 
NaOH adjusted to pH 7.0 
autoclaved 
 DH5α 
LBAmp sterile LB0 100μg/ml ampicillin DH5α 
Agar plates LBAmp  1.5% agar DH5α 
DMEM (Dullbecco’s 
modified eagle 
medium 
See manufacturer’s 
product information 
(Gibco) 
10% FBS (fetal bovine serum; PAN) 
100μg/ml penicillin (PAN) 
100μg/ml streptomycin (PAN) 
293 
Ham’s 12 (Invitrogen) 
See manufacturer’s 
product information 
(Gibco) 
10% FBS (fetal bovine serum; PAN) 
2mM L-Glutamine (PAN) 
100μg/ml penicillin (PAN) 
100μg/ml streptomycin (PAN) 
100μg/ml zeocin or 500μg/ml hygromycin 
CHO 
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MEM-α See manufacturer’s 
product information 
(Gibco) 
10% FBS (fetal bovine serum; PAN) 
100μg/ml penicillin (PAN) 
100μg/ml streptomycin (PAN) 
2mM L-Glutamine (PAN) 
1% NEAA (non essential amino acids) 
P19  
 
 Kits 6.4
Name Application  Supplier 
CCL3/MIP-1 alpha DuoSet Mouse  ELISA  R&D 
EpiTect Bisulfite-Kit  Bisulfite Converision Qiagen   
QIAamp DNA Mini Kit  gDNA Isolation  Qiagen 
QIAGEN Plasmid Maxi Kit  pDNA Isolation  Qiagen 
QIAGEN Plasmid Midi Kit  pDNA Isolation  Qiagen 
QIAquick Gel Extraction Kit  Gel extraction of DNA fragments  Qiagen 
QIAquick PCR Purification Kit  Purification of DNA fragments  Qiagen 
 Buffers and reagents 6.5
 
Buffer/reagent Composition Application  
APS  10% Ammoniumperoxidsulfat in H2O PAGE 
ChIP buffer IA 
10mM HEPES/KOH pH 7.9 
85mM KCl 
1mM EDTA 
1x protease inhibitor cocktail (Roche) 
Phosphatase inhibitor cocktail SetV 
(Calbiochem, 524629) 
ChIP 
ChIP buffer IB 
10mM HEPES/KOH pH 7.9 
85mM KCl 
1mM EDTA 
10% Nonidet P-40 
1x protease inhibitor cocktail (Roche) 
Phosphatase inhibitor cocktail SetV 
(Calbiochem, 524629) 
ChIP 
ChIP buffer II 
50mM Tris/HCl pH 7.4 
1% SDS, 0.5% Empigen BB 
10mM EDTA pH 8.0 
1x protease inhibitor cocktail (Roche) 
ChIP 
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ChIP dilution buffer 150 mM NaCl  
20mM Tris–HCl pH 8.1 
1.2mM EDTA 
1% Triton X-100 
0.01% SDS  
Protease inhibitor cocktail (Roche)  
Phosphatase inhibitor cocktail SetV 
(Calbiochem, 524629)  
ChIP 
ChIP low salt buffer 
20mM Tris [pH 8.1] 
150 mM NaCl 
2 mM EDTA 
1% Triton X-100 
0.1% SDS 
ChIP 
ChIP high salt buffer 
20mM Tris [pH 8.1] 
0.5M NaCl 
2mM EDTA 
1% Triton X-100 
0.1% SDS 
ChIP 
DNA sample buffer (6x)  
 
0.001% Bromphenol blue (w/v)  
0.001% Xylene cyanol (w/v)  
50mM EDTA pH 8.0  
30% Glycerin (w/v)  
Agarose Gel 
electrophoresis 
FAIRE buffer IA 
10mM HEPES/KOH pH 7.9 
85mM KCl 
1mM EDTA 
1x protease inhibitor cocktail (Roche) 
FAIRE 
FAIRE buffer IB 
10mM HEPES/KOH pH 7.9 
85mM KCl 
1mM EDTA 
10% Nonidet P-40 
1x protease inhibitor cocktail (Roche) 
FAIRE 
FAIRE buffer II 
50mM Tris/HCl pH 7.4 
1% SDS 
0.5% Empigen BB 
10mM EDTA pH 8.0 
1x protease inhibitor cocktail (Roche) 
FAIRE 
FACS buffer 
1mg/ml NaN3 
1% FCS 
in PBS 
Flow cytometry 
Fixation solution 
2% formaldehyde (v/v) 
0.2% glutaraldehyde (v/v) 
In PBS 
X-Gal staining 
High Salt buffer 
10mM Tris/HCl ph 7.6 
2M NaCl 
1mM EDTA 
0.05% NP40 
1mM ß-mercaptoethonol  
Nucleosome reconstitution 
Laemmli sample buffer (6x)  
 
300mM Tris/HCl pH 6.8  
12% SDS (w/v)  
60% Glycerin (w/v)  
10% Mercapto ethanol (v/v)  
0.025% Bromphenol blue 
PAGE 
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LiCl buffer 10mM Tris [pH 8.1] 
0.25M LiCl 
1mM EDTA 
1% Igepal-CA630 
1% deoxycholic acid) 
ChIP 
Low salt buffer 
10mM Tris/HCl ph 7.6 
50mM NaCl 
1mM EDTA 
0.5% NP40 
1mM ß-mercaptoethonol 
Nucleosome reconstitution 
native PAA gel (5%) 
8.3ml Acrylamide (Rotiphorese; 30%) 
41.6ml 0.4x TBE 
300μl APS (10%) 
30μl TEMED 
Native PAGE 
PBS 
7mM Na2HPO4 
3mM NaH2PO4 
130mM NaCl 
Diverse applications 
PBS-T  PBS with 0.5% Triton X-100 ELISA 
Ponceau solution  
2% Ponceau red  
3% trichloroacetic acid (TCA) 
Western blot 
RIPA buffer 
50mM Tris/HCl pH 8.0  
150mM NaCl  
0.1% SDS (w/v)  
1% Nonidet P-40 (w/v)  
0.5% Natriumdesoxycholat (w/v) 
2 tablets protease inhibitor (complete mini; 
Roche) 
Cell lysis 
TE buffer 
10mM Tris [pH 8.0]  
1mM EDTA 
Diverse applications 
TBE Buffer (10x)  
1M Tris  
1M Boric acid 
20mM EDTA pH 8.0 
Agarose gel 
electrophporesis 
Native PAGE 
TBS buffer 
150mM NaCl  
50mM Tris/HCl pH 7.5 
Western blot 
Transfer buffer pH 8.3  
0.3% Tris  
1.45% Glycin  
20% Methanol  
0.2% SDS 
Western blot 
Trypan blue reagent 0.5% Trypan blue Cell staining 
TTBS  0.05% Tween-20 in TBS Western blot 
X-gal staining reagent 
4mM Ferricyanid  
4mM Ferrocyanid  
2mM MgCl2  
5% X-Gal (20mg/ml in Dimethylsulfonamid 
(DMSO) 
X-gal staining 
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 Plasmids 6.6
Plasmid Supplier 
pcDNA5/FRT  V6010-20 (Invitrogen) 
pOG44  V6005-20 (Invitrogen) 
pcDNA5-CMV-mMIP-wt/13/0/42 Kindly provided by Dr. Bauer [170] 
pcDNA5-CMV-hGFP-0/60 Kindly provided by Dr. Leikam [169] 
pcDNA5-EF-1α-hGFP-0/60 Adopted from previous studies [186] 
pcDNA3.1-VSV-G Kindly provided by Dr. Alexander Kliche 
psPAX2 Kindly provided by Dr. Alexander Kliche  
pHR'SINcPPT-EF1α -eGFP-WPRE 
Kindly provided by Dr. Zhang, Institute of Child 
Health, UCL, London, UK 
pHR’SINcPPT-UCOE-EGFP-WPRE 
Kindly provided by Dr. Zhang, Institute of Child 
Health, UCL, London, UK 
 Oligonucleotides  6.7
 
Name Sequence (5’-3’) Application 
Bis-CMV5' fwd TTGTATGAAGAATTTGTTTAGGG Bisulfit sequencing 
Bis-CMV5' rev TAATACCAAAACAAACTCCCAT Bisulfit sequencing 
Bis-CMV3' fwd GGATTTTTTTATTTGGTAGTATATTTA Bisulfit sequencing 
Bis-CMV3' rev CTCTAATTAACCAAAAAACTCTACTTATAT Bisulfit sequencing 
Bis-hGFP60-5’ (915) fwd TTGTTATTATGGTGAGTAAGGG Bisulfit sequencing 
Bis-hGFP60-5’ (1359) rev TAATTATACTCCAACTTATACCCCA Bisulfit sequencing 
Bis-huGFP60-3’ (1206)-fwd AGGAGTGTATTATTTTTTTTAAGGA Bisulfit sequencing 
Bis-huGFP60-3’ (1685)-rev TAAATATCTACAAAATTCCACCACA Bisulfit sequencing 
EcoRI-pc5/6351-2043-fwd ATCGAATTCAGGCGTTTTGCG Cloning of pHR vectors 
GFP0_I_rev TGCTGCTTCATGTGGTCTGG Nucleosome reconstitution 
GFP0_II_fwd GTGCAGTGCTTCAGCAGATACC Nucleosome reconstitution 
GFP0_II_rev TGCCATTCTTCTGCTTGTCTG Nucleosome reconstitution 
GFP0_III_ fwd ATGTGTACATCATGGCAGACAAG Nucleosome reconstitution 
GFP60_I_rev TGCTGCTTCATGTGGTCGGG Nucleosome reconstitution 
GFP60_II_fwd GTGCAGTGCTTCAGCCGC Nucleosome reconstitution 
GFP60_II_rev TGCCGTTCTTCTGCTTGTCG Nucleosome reconstitution 
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GFP60_III_fwd ACGTCTATATCATGGCCGACA Nucleosome reconstitution 
GFP ORF 954 fwd GGGTGGTGCCCATCCTGGT FAIRE 
GFP ORF 1074 rev GTGGTGCAGATGAACTTCAGGGT FAIRE 
NdeI(2)-pHR/9666-2974 rev TATCATATGCGATGCGGGGAGG Cloning of pHR vectors 
rDNA fwd GGCGGACTGTCCCCAGTG FAIRE 
rDNA rev GTGGCCCCGAGAGAACCTC FAIRE 
SalI-pHR/9691-650 fdw TACGTCGACTGGCTAGCGTTTAAAC Cloning of pHR vectors 
SbfI-pc5/6351-2043-rev ATCCTGCAGGCCACACTGGACTA Cloning of pHR vectors 
TSS fwd AGAGAACCCACTGCTT ACT GG CTTA FAIRE 
TSS rev GCTAGCCAGCTTGGGTCT CCC TA FAIRE 
ß-Actin-2781-fwd ACCACCATGTACCCAGGCATTG FAIRE 
ß-Actin-3020-rev GAGCCACCGATCCACACAGAGT FAIRE 
ß2-M fwd CGAGACATGTAAGCAGCATC FAIRE 
ß2-M rev GCAGGTTGCTCCACAGGTA FAIRE 
3’UTR fwd CTCGAGTCTAGAGGGCCCGTTT FAIRE/ChIP 
3’UTR rev GAGGGGCAAACAACAGATGG 
FAIRE/ChIP 
 
 Chemicals, enzymes and materials 6.8
All chemicals were supplied by SIGMA-ALDRICH, FLUKA CHEMIE, Roth or MERCK. 
Enzymes were supplied by NEB.  
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7  
 Cultivation of eukaryotic cells 7.1
 Maintenance of cell lines 7.1.1
Cell culture media and supplements were supplied by PAN Biotech or Invitrogen. 
Culture vessels were purchased from Greiner or BD Bioscience. All eukaryotic cell 
lines were maintained in an atmosphere consisting of 37°C and 5% CO2. HEK 293 
cells were grown in DMEM medium, CHO cells were cultivated in Ham’s F12 medium 
and P19 cells were maintained in MEM-α medium, containing the respective 
supplements (see 6.3).  
 Transient transfections 7.1.2
Transient transfections were performed using polyethylenimine (PEI; PeqLab) [149]. 
Cells were seeded (3x105 cells/6-well plate/3ml media) 24h before transfection. The 
medium was replaced with antibiotic- and FBS-free medium and cells were 
transfected with the respective expression vector(s). A total of 2µg DNA (6-well) and 
8μl of a 1mg/ml PEI in H2O solution, each ad 100μl NaCl, was mixed on a vortex 
device, left standing for 10min at room temperature and added drop-wise to the cell 
suspension. Transfection medium was replaced 6h later with 3ml of supplemented 
growth medium. For transfection in a smaller or larger vessel, the volume of DNA 
and all transfection reagents was scaled up or down accordingly. 
 Establishment of plasmid-based stable cell lines 7.1.3
The establishment of stable cell lines was achieved using the Flp-In system 
(Invitrogen). A lacZ-zeocin gene, controlled by the SV40 promoter, is stably 
integrated within a defined region of the CHO Flp-In genome. A FRT-region is 
located downstream of the promoter and the ATG start codon and provides a site for 
homologous recombination mediated by the Flp recombinase. The expression vector 
pcDNA5/FRT contains an identical FRT site. CHO Flp-In cells were transfected with 
the Flp-recombinase expression plasmid pOG44 together with pcDNA5/FRT 
including the transgene. As a result, the transgene is introduced into the host cell 
within a defined genomic region. The selection of positive transfectants is obtained 
by a hygromycin resistance gene, located within pcDNA5/FRT.  
CHO cells were stably transfected employing PEI as previously described (7.1.2). A 
total of 2μg plasmid DNA (6 well) was transfected at a pOG44:pcDNA5 rate of 9:1. 
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Procedure of transfection, number of seeded cells and amount of reagents was 
analogous to transient transfections. The medium was supplemented with gradually 
increased concentrations of Hygromycin B (50μg/ml–500μg/ml within approximately 
3 weeks) which led to the selection of positive cell clones.    
 Lentiviral vector (LV) preparation and transduction of cell 7.1.4
lines  
LVs were produced by transient co-transfection of HEK 293 cells with the envelope 
plasmid pcDNA3.1-VSV-G, the packaging plasmid psPAX2, and the respective 
lentiviral vector (see 7.5.5) at a molar ratio of 1:3:4, employing PEI as previously 
described (7.1.2). Cells were harvested 48h post transfection and cleared by 
centrifugation at 3000g for 10min. The supernatants containing the viruses were 
loaded onto a 30% sucrose cushion in PBS and ultra-centrifuged at 130000g for 2h. 
The pellets were resuspended in cold PBS and left on ice for 1h. After thorough 
resuspension of the viruses, the liquid was transferred to an eppendorf tube and 
centrifuged at 14000g at 4°C for 5min to remove any remaining debris. The virus 
stock was aliquoted and stored at -80°C. The titer of LVs was determined by 
transducing HEK 293 cells with virus serial dilutions and monitoring expression after 
three days by flow cytometry. Lentiviruses containing hGFP-0 and hGFP-60, 
respectively, under control of the CMV, EF-1α or A2UCOE promoters were used to 
transduce P19 cells at different MOIs to reach a similar amount of positive cells.  
 Cultivation of prokaryotic cells 7.2
For the cloning of DNA fragments and amplification of plasmids, E.coli strain DH5α 
(f- supE44 ΔlacU169 (φ80 lacZΔM15) hsdR1 recA1 endA1 gyrA96 thi1 relA1) was used. 
Bacteria were grown in LB medium or on agar plates, supplemented with ampicillin 
(100μg/ml) if required, at 37°C.   
 DNA methods  7.3
 Isolation of genomic DNA  7.3.1
Genomic DNA was isolated using the QlAmp DNA Mini Kit (Quiagen) according to 
the manufacturers’ instructions. The method is based on cell lysis by detergent and 
the degradation of proteins by Proteinase K. Additionally, RNAseA was used to 
prevent RNA contamination. DNA was eluted in 200μl sterile H2O and stored at -20°. 
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 DNA quantification 7.3.2
The DNA amount and purity was determined using the Nanodrop (Peqlab). 1.5μl of 
DNA sample was pipettet onto the pedestral. The absorbance of the DNA sample was 
measured within a range from 220nm–300nm. All absorbance values were 
normalized to the DNA solvent reagent. 
 Agarose gel electrophoresis 7.3.3
DNA was separated using 1 – 1.5% (W/V) agarose gels, depending on the fragment 
size. Gels were prepared with 1xTBE buffer, mixed with 0.5mg/l ethidium bromide. 
DNA samples were mixed with 6x running dye. Molecular weight standard (NEB) 
consisted of 100bp, 1kb or 2-log ladder. Gels were electrophoresed in the 
corresponding buffer at 80 – 200V, depending on the size of the gel. DNA was 
detected by ultraviolet exposure. 
 DNA purification from agarose gels 7.3.4
DNA was purified from gels using the QlAquick Gel Extraction Kit (Qiagen) 
according to the manufacturers’ instructions. DNA was usually eluted in H2O.  
 In vitro methylation 7.3.5
Methylation of phGFP-60 was carried out using the the M.SssI methylase (NEB) 
according to the manufacturer’s protocol. Quantitative methylation was verified by 
digestion of 1 µg methylated DNA with the CG methylation insensitive enzyme SacI 
and the CG methylation sensitive restriction enzyme ApaI (both from NEB) for 1h at 
37 °C. Plasmids were subsequently purified using the PCR purification Kit (Qiagen). 
 Bisulfite conversion and sequence analysis 7.3.6
Genomic DNA was isolated from cells using the QIAamp DNA Mini Kit (Qiagen) 
according to the manufacturer’s instructions. Sodium bisulfite treatment of genomic 
DNA was performed to convert unmethylated cytosine to thymine residues using the 
EpiTect Bisulfite-Kit (Qiagen) according to the manufacturer’s instructions. Primers 
used for bisulfite treated DNA amplification were designed based on converted 
sequences (6.7). Primer binding sites were devoid of CpGs to allow equal 
amplification of methylated and unmethylated DNA. PCR products of bisulfite 
converted DNA were separated by gel electrophoresis and bands of the appropriate 
size were cut out, purified by the QIAquick Gel Extraction Kit (Qiagen) and sent to 
Geneart/Life techonologies for sequencing. Sequence alignment was conducted by 
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the software Lasergene DNAstar (Seqman; v5.0.3) and chromatograms were analyzed 
by the software Chromas (Version 2.32, Technelysium). The methylation levels of 
CpG dinucleotides were determined by measuring the ratio of each of the cytosine 
peak heights to the sum of respective cytosine and thymine peak heights in 
automated DNA sequencing traces, according to a technique published by Jiang et al 
[182]. The evaluation and presentation of methylation levels was done by the software 
Excel 2010.    
 Polymerase chain reaction (PCR) 7.4
PCR was performed using the myCycler (Biorad) or the PCR Thermal Cycler Gene 
Amp 2400 (PerkinElmar). Real-time PCR was performed using the StepOnePlus Real-
Time PCR system (Applied Biosystems). Primers were usually designed using the 
online software Primer3 (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi). 
 Quantitative PCR/real-time PCR 7.4.1
Quantitative PCR (qPCR) was performed to evaluate copy count numbers or to 
quantify nucleosome depleted (FAIRE) and immunoprecipitated (ChIP) DNA, 
respectively. The DyNAmo™ Flash SYBR® Green qPCR Kit (Finnzymes) and the 
TaqMan® Genotyping Master Mix (Life technologies), respectively, were used for 
qPCR applications according to the manufacturer´s protocol. Quantitative 
amplification was carried out in a StepOnePlus real-time PCR system (Applied 
Biosystems). Product specificity was assessed based on melting curves. Fluorescence 
was measured and expressed as crossing point (Cp) when exceeding background 
fluorescence of the PCR master mix by the StepOne Software v2.2.2 (Applied 
Biosystems). 
For relative quantification analyses of hgfp transgene copy number in CHO Flp-In 
cells, the DyNAmo™ Flash SYBR® Green qPCR Kit (Finnzymes) was used. For hgfp 
copy number determination in P19 cells, a predesigned Custom TaqMan® Copy 
Number Assay (Life technologies) targeting the Woodchuck Hepatitis Virus (WHP) 
Posttranscriptional Regulatory Element (WPRE) element was applied. For relative 
quantification, this assay was combined with the TaqMan® Copy Number Reference 
Assay (Life technologies) specifically binding to the endogenous mouse telomerase 
reverse transcriptase (mtert). 
PCR efficiencies (E) were determined by evaluation of serial dilutions of the 
respective templates. E can be calculated from the slope of the standard curve:  
E= 10-1/slope. Primers were designed such that the E was approximately 2. Data were 
analyzed using the 2ΔΔCT method. 
The procedures for qPCR following ChIP and FAIRE analyses are specified in the 
respective sections below.  
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 DNA sequencing 7.4.2
Sequence analyses of several genes were performed by the company Geneart AG/life 
technology according to the Sanger method. Evaluation was performed with the 
software Lasergene DNAstar (Seqman; v5.0.3) or the online software Chromas 
(Version 2.32, Technelysium).  
 Plasmid construction 7.5
 Ligation 7.5.1
Ligations were set up in a total v0lume of 10μl, consisting of 1:3 concentrations of 
prepared vector DNA and respective insert, 1μl of 10x ligase buffer, 1μl T4 ligase (NEB) 
and an appropriate volume of H2O. Ligations were performed at RT for 1h. 
 Transformation of E.coli  7.5.2
100μl of frozen competent DH5α cells were thawed on ice following addition of the 
complete ligation volume and incubation on ice for 20 min. The heat shock was 
performed at 42°C for 45sec. 900μl of LB0 medium was added and cells were 
incubated at 37°C for 1h. After centrifugation and resuspension in 200μl LB0 cells were 
plated on LBAmp agar and incubated at 37°C o/n. Positive cell clones were identified by 
means of colony PCR and restriction analyses after plasmid isolation.  
 Preparation of plasmid DNA 7.5.3
Plasmid DNA used for analytic purposes such as DNA sequencing was extracted 
according to the alkaline lysis. 2ml of an o/n bacteria culture were centrifuged (13000 
rpm; 1 min; RT) and resuspended in 200μl buffer P1 (Quiagen). Subsequently, 200μl 
lysis buffer P2 was added and the mixture was incubated at RT for 5 min. Lysis was 
stopped by adding 200μl buffer P3 (Quiagen). The samples were incubated at ice for 5 
min followed by centrifuging twice (13000 rpm; 1 min; RT). After each centrifugation 
step, the DNA present in the supernatant was transferred into a fresh eppendorf tube 
and subsequently precipitated by addition of 0.8 volumes isopropanol, followed by 
centrifugation (13000 rpm; 30 min; 4°C). The DNA precipitate was washed with 70% 
ethanol and eluted in 50μl sterile H2O. For the extraction of larger DNA amounts 
with high purity, plasmid DNA was isolated by using Midi- or Midi Kits (Quiagen) 
according to the manufacturers’ instructions.  
Methods 
Page | 86  
 
 Cloning of hgfp chimera 7.5.4
All hgfp chimera were created by fusion PCR using the plasmid pcDNA5-CMV-hGFP-
o and pcDNA5-CMV-hGFP-o as template and corresponding primers listed in 6.7. 
Amplified inserts were subsequently cloned into pcDNA5 containing the CMV 
promoter via HindIII and BamHI, thereby replacing hgfp, to give the gene chimera 
pcDNA5-hGFP-5’25CpG, pcDNA5-hGFP-5’13CpG and pcDNA5-hGFP-3’21CpG. 
 Cloning of lentiviral transgene vectors 7.5.5
The lentiviral (LV) vectors pHR'SINcPPT-EF1α-eGFP-WPRE and 
pHR’SINcPPT-UCOE-EGFP-WPRE (kindly provided by Dr. Zhang, Institute of Child 
Health, UCL, London, UK) served as basis for LV construction. The UCOE element 
was created as previously described [233]. The element EF1α-eGFP was released from 
pHR'SINcPPT-EF1α-eGFP-WPRE via EcoRI and SbfI. The elements CMV-hGFP-0, 
CMV-hGFP-60, EF1α-hGFP-0 and EF1α-hGFP-60 were obtained by amplification from 
the plasmids pcDNA5-CMV/EF-1α-hGFP0/60, thereby obtaining the restriction sites 
EcoRI and SbfI. CMV-hGFP-0, CMV-hGFP-60, EF1α-hGFP-0 and EF1α-hGFP-60 were 
subcloned into pHR'SINcPPT-WPRE via EcoRI and SbfI to obtain 
pHR'SINcPPT-CMV-hGFP-0-WPRE, pHR'SINcPPT-CMV-hGFP-60-WPRE, 
pHR'SINcPPT-EF1α-hGFP-0-WPRE and pHR'SINcPPT-EF1α-hGFP-60-WPRE. Using 
pHR'SINcPPT-CMV-hGFP-0-WPRE and pHR'SINcPPT-CMV-hGFP-60-WPRE as a 
template, hGFP-0 and hGFP-60 were amplified and cloned into 
pHR’SINcPPT-UCOE-EGFP-WPRE via SalI and NdeI, thereby replacing eGFP and 
creating pHR'SINcPPT-UCOE-hGFP-0-WPRE and 
pHR'SINcPPT-UCOE-hGFP-60-WPRE.  
 Protein methods 7.6
 Determination of protein amount according to Bradford 7.6.1
The total protein amount was analyzed spectrophotometrically according to the 
method of Bradford by using the “Biorad-protein-assay” reagent (Biorad)[238]. The 
protein amount was determined by a BSA standard curve.  
 Enzyme linked Immunosorbent Assay (ELISA) 7.6.2
Quantification of mMIP-1α in cell culture supernatants was performed in 96-well 
MaxiSorb-plates (Nunc) using a commercial ELISA kit (CCL3/MIP-1 alpha DuoSet 
Mouse; R&D) according to the manufacturers' instructions. The washing was 
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performed using the application platform hydro flex (Tecan). Antigen-antibody 
complexes were detected with a TMB substrate solution (BD Bioscience) according to 
manufacturers' instructions and read out at a wavelength of 450nm using a 
spectrophotometer (Biorad; 680 Microplate Reader). MIP-1α concentration was 
determined by a standard curve in which a known concentration of mMIP-1α was 
plotted against the intensity of the emitted signal.  
 Flow cytometry 7.6.3
hGFP expression was analyzed by flow cytometry. At least 3x 105 cells were washed in 
500μl PBS scraped off and centrifuged (300g; 5min; RT). The washing was repeated 
before cells were resuspended in 200μl FACS buffer.  
hGFP fluorescence of a cell population of at least 10000 cells was detected using 
the flow cytometer FACS Canto II device (BD, FACS Diva v6.1.3 software). Results 
were evaluated by the FACS Diva v6.1.3 software and statistic calculations were 
performed using the Excel software 2010.  
 Formaldehyde-assisted isolation of regulatory 7.7
elements (FAIRE) 
FAIRE was essentially performed according to a published protocol [239]. 
Approximately 3x107 exponentially growing CHO and HEK 293 Flp-In cells, 
respectively, stably expressing hGFP, respectively, mMIP-1α variants, were cross-
linked for 7 min at RT with 1% formaldehyde added directly to the culture medium. 
The reaction was quenched by the addition of glycine to a final concentration of 
125mM. Cells were scraped off, washed twice with ice-cold phosphate-buffered saline 
and collected by centrifugation (700 × g; 5 min; 4°C). The cell pellet was snap-frozen 
at -80°C for storage or directly resuspended in FAIRE buffer IA and lysed on ice for 10 
min in FAIRE buffer IB (For buffer composition, see chapter 6.5). Cell lysate was 
centrifuged at 700g for 5min and cell nuclei lysed in FAIRE buffer II. Samples were 
sonicated using a Bioruptor sonicator (Diagenode) to yield approximately 200-500bp 
DNA fragments. Cell debris was spun at 16100g for 5min and the clarified supernatant 
was treated with RNAse A at a final concentration of 0.33µg/µl for 1-2h at 37°C. 25% of 
the sheared chromatin was isolated, treated with proteinase K (0.5µg/µl) at 56°C for 
1h and reverse cross-linked o/n at 65°C. Released DNA was isolated by adding an 
equal volume of phenol-chloroform/isoamyl alcohol (25:24:1) in Phase Lock Gel Light 
Tubes (5Prime). The remaining 75% of sheared chromatin was directly extracted by 
phenol chloroform in the same way without prior proteinase K treatment and reverse 
cross-link. DNA from the aqueous phase of both chromatin fractions (with/without 
reverse cross-link) was subsequently precipitated by the addition of ammonium 
acetate (pH 7.5) to a final concentration of 2.5M and an equal volume of isopropanol 
followed by an overnight incubation at −20°C. The precipitate was collected the next 
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day by centrifugation for (30min; 16000g; 4°C), washed with 70% ethanol, air dried, 
and resuspended in 200µl double-distilled water.  
Quantification of purified DNA was carried out by real-time PCR using the 
DyNAmo Flash SYBR® Green qPCR Kit from Finnzymes according to the 
manufacturer's instructions. Primers were designed to cover the TSS, ORF (for hGFP 
variants), 3’UTR (for mMIP-1α variants), the second exon-intron junction of ß-2-
microglobulin (ß2-m) and rdna (see chapter 6.7). Data were analyzed using the 2ΔΔCT 
method. All results were normalized to rdna and referred to hGFP-0 and mMIP-wt, 
respectively. They are presented as the ratio of DNA recovered from crosslinked cells 
divided by the amounts of the same DNA in the corresponding non-crosslinked 
samples. Data evaluation and statistical calculations were conducted using the Excel 
software 2010 and the software GraphPad Prism v.4. For all FAIRE evaluations, the 
ANOVA/ Tukey's multiple comparison test was used. 
 Chromatin Immunoprecipitation (ChIP) 7.8
Approximately 3x107 recombinant CHO and HEK 293 Flp-In cells stably expressing 
mMIP-1α variants were cross-linked by 1% formaldehyde for 12min. The reaction was 
quenched by 0.125M glycine. Cells were washed three times in 1× PBS, collected into 
ChIP buffer IA and lysed in ChIP buffer IB on ice for 10min. Cell lysate was 
centrifuged (700xg; 5min) and pelleted cell nuclei were lysed in ChIP buffer II. 
Samples were sonicated using a Bioruptor sonicator (Diagenode) to yield 
approximately 300-800bp DNA fragments. Cell debris was spun at 16100g for 5min 
and the cleared chromatin stored at -80°C. Approximately 2x106 cells were used for 
one Immunoprecipitation (IP) reaction. Additionally, 20% of each sonicated sample 
was removed as Input fraction to calculate the Output/Input ratio in subsequent IPs. 
Sheared chromatin samples were diluted 1:10 in dilution buffer and precleared with 
rotation for 2h with 60μl protein A agarose/salmon sperm DNA slurry (Millipore) at 
4°C. Precleared chromatin was incubated with the appropriate antibody (see table 
below) at 4°C overnight with gentle rotation. The retained Input fraction was likewise 
diluted 1:10 in dilution buffer and isopropanol precipitated by 2.5M ammonium 
acetate overnight. Antibody-chromatin complexes were precipitated the next day by 
incubation with 60μl protein A agarose/salmon sperm DNA slurry for 4h at 4°C with 
gentle rotation, followed by centrifugation (5min; 500g; 4°C). The supernatant was 
aspirated, and the pellet was washed consecutively with 1ml each of ChIP low-salt 
buffer ChIP high-salt buffer, lithium chloride (LiCl) buffer, and twice with TE buffer. 
After final aspiration of the washed beads, a total of 100 µl of 10% Chelex (Biorad) 
(10g; 100ml H2O) was added to the Output samples and the precipitated 20% Input 
fraction. After 15min of boiling, Proteinase K (100µg/ml) was added to the 
Chelex/protein A bead suspension and incubated for 1.5 h at 56 °C while shaking, 
followed by another 15min of boiling. The suspension was then applied onto Micro 
Bio-Spin Columns (Bio-Rad) and centrifuged at 500g for 5min for purification of 
nucleic acids. The eluate was used directly as a template in quantitative PCR. Primer 
Methods 
Page | 89  
 
were designed to cover a 83bp 3’region of the CMV promoter, a 83bp region 
immediately downstream the open reading frame (3’UTR) of mMIP-1α and a 69bp 
sequence of the first exon-intron junction of gapdh (see chapter 6.7). Data were 
analyzed using the 2ΔΔCT method and reported as Output to Input fraction or as the 
relative enrichment of immunoprecipitated DNA by the specific antibody at the 
respective gene of interest (GOI) normalized to the endogenous control gene (gapdh) 
and relative to the Input, minus the respective IgG signal, according to the formula: 
 
 
 
Data evaluation and statistical calculations were conducted using the Excel software 
2010 and the software GraphPad Prism v.4. 
 
Antibody Description 
Conc. 
per IP 
Manufacturer/ 
catalogue no 
α-H3 Rabbit polyclonal against Histone H3 5µg Abcam, 1791 
α- H3K4me3 Rabbit polyclonal against Histone H3K4me3 5µg Abcam, ab8580 
α-RNAPII 
Rabbit polyclonal antibody against 
a peptide mapping at the N-terminus of Pol II of 
mouse origin (N-20) 
7,5µg Santa Cruz, sc-899 X 
α-Ser2P RNAPII 
Rabbit polyclonal against RNAPII CTD repeat 
YSPTSPS (phospho S2) 
7.5µg Abcam, ab5095 
α-FLAG 
Polyclonal rabbit against the FLAG epitope; peptide 
sequence DYKDDDDK 
7.5µg Sigma Aldrich, F7425 
α-IgG IgG from rabbit serum 5µg 
Sigma Aldrich, I5006-
10MG 
 Analysis of reconstituted mononucleosomes in vitro 7.9
 Amplification of CpG fragments for nucleosome 7.9.1
reconstitutions 
hGFP fragments used in reconstitution assays were generated by PCR using the 
according primers (see 6.7) and purified using the QIAquick PCR Purification Kit 
(Qiagen) according to the manufacturers' instructions. Before use in reconstitution 
assays, fragments were diluted in H2O to a concentration of 0.3-0.5μg/μl.  
 Nucleosome assembly by salt dialysis 7.9.2
hGFP fragments generated by PCR were incorporated into mononucleosomes using 
the salt dialysis technique [185]. Core histones, extracted from Drosophila embryos, 
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were kindly provided by Prof. Dr. Längst (Regensburg). An arbitrary plasmid 
(pUC 19) was used as competitive DNA. BSA was added to the reaction and low 
binding reaction tubes (Biozym) were used to avoid adherence of nucleosomes to the 
tube walls. In order to determine the optimal histone: DNA ratio for a given 
combination of gene variants, a test assembly was performed in which increasing 
amounts of histone octamers were added to a constant amount of DNA. A typical test 
assembly contained histone: DNA ratios of 0:1, 0.8:1, 1:1, 1.2:1, 1.4:1, 1.6:1 and 1.8:1. All 
additional reaction compounds are listed in Table 1. The ideal ratio was selected for 
nucleosome positioning. For subsequent comparative analyses, the histone:DNA 
ratio was used in which approximately 70% of the DNA was incorporated into 
nucleosomes. Large histone-DNA complexes resulting from high histone 
concentrations were avoided. A typical assembly reaction was prepared in low 
binding reaction tubes as follows:  
Table 1 | Typical assembly set-up. * The optimal amount of histones 
was detected in a test assembly, described above 
volume component  
1μl BSA (10mg/μl) 
4μl gene variant (0.3μg/μl) 
4μl competitive plasmid (0.5μg/μl) 
xμl (*)
 
purified octamers (1μg/μl) 
ad 50μl high salt buffer 
 
The salt concentration of the high salt buffer was gradually decreased by the addition 
of low salt buffer via pipes using a peristaltic pump (150ml/h). Analysis of 
mononucleosomes was performed by native PAGE, loading approximately 700ng 
nucleosomes in each lane.  
 Analysis of mononucleosomes by Native PAGE 7.9.3
Native PAGE was used to characterize reconstituted mononucleosomes. Free DNA 
migrates faster through native gels than nucleosomes incorporated with the same 
DNA. Nucleosomes positioned at the end of a DNA fragment migrates faster that a 
nucleosome formed in the center of a DNA fragment. Native 5% PAA gels (for 
composition see 6.5) were prepared using the Novex-System (Invitrogen) according 
to the manufacturers' instructions. The gel cassette was set into the electrophoresis 
chamber and filled with 0.4xTBE Buffer, before nucleosome samples and a DNA 
ladder were seeded into the wells. Mononucleosomes were separated at a constant 
voltage of 100V for 80min. Nucleoprotein complexes were stained with ethidium 
bromide followed by ultraviolet exposure.  
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9  
 List of abbreviations 9.1
A  
5’aza 5-Azacytidine -2'-deoxycytidine 
A2UCOE 
heterogeneous nuclear ribonucleoprotein A2/B1- 
chromobox homolog 3 ubiquitously chromatin 
opening element 
ApG adenin guanine dinucleotide 
APS ammoniumperoxidsulfat 
  
B  
BB bacterial backbone 
BGH bovine growth hormone  
bp base pair 
BSA bovine serum albumin 
  
C  
CAI codon adaptation index 
CAP chromatin associated protein 
CBX3 chromobox homolog 3 
CFP-1 CXXC finger protein 1 
CGBP-1 CpG-binding protein 1 
CHD chromodomain-helicase-DNA binding 
ChIP chromatin immunoprecipitation 
CHO chinese hamster ovaries 
CMV cytomegalovirus 
CP crossing point 
CpG  cytosine guanine dinucleotides 
CpT cytosine thymine dinucleotides 
CREB cAMP response element-binding protein 
CTCF CCCTC binding factor 
CTD Carboxy-terminal domain 
  
D  
DBD DNA binding domain 
DMEM Dullbecco’s modified eagle medium 
DNA  Deoxyribonucleic acid 
DNMT DNA methyltransferase 
DPE downstream promoter element 
DRB 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole 
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DRE distal regulatory element 
DSIF DRB sensitivity-inducing factor 
  
E  
E efficiency 
EC expression cassette 
EDTA ethylenediaminetetraacetic acid 
EF-1α elongation factor 1α 
EGTA ethylene glycol tetraacetic acid 
ELISA enzyme linked immunosorbent assay 
ELL eleven-nineteen lysine-rich 
  
F  
FACS fluorescence activated cell sorting 
FAIRE 
formaldehyde assisted isolation of regulatory 
elements 
FBS fetal bovine serum 
Flp flippase 
FRT flp recombination target 
  
G  
GAPDH glyceraldehyde-3-phosphate dehydrogenase 
GFP green fluorescent protein 
GTF general transcription factor 
  
H  
HAT histone acetyl transferase 
hCGBP human CpG binding protein 
HDAC  histone deacetylase  
HEK 293  human embryonic kidney cells 293 
hGFP humanized green fluorescent protein 
HIV human immunodeficiency virus 
HNRPA2B1 heterogeneous nuclear ribonucleoprotein A2/B1 
hph hygromycin resistance gene 
HRP horseradish peroxidase 
  
I  
IgG immunglobulin G 
IGR intergenic region 
Inr initiator 
IOD integrated optical density 
ISWI imitation switch 
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K  
kb kilobase 
kDa kilo Dalton 
KDM2A lysine demethylase enzyme 2A 
  
L  
lacZ encodes ß-galactosidase  
LB Luria Bertani 
LINE long interspersed nuclear elements 
LTR long terminal repeat 
LV lentivirus 
  
M  
M molar 
MBD methyl CpG-binding domain proteins 
MBD methyl-DNA binding domain 
ME mercaptoethanol 
MeCP methyl CpG binding protein 
MED mediator complex 
mEPO murine erythropoietin 
MFI mean fluorescence intensity 
MHC major histocompatibility complex 
min minutes 
mMIP-1α murine macrophage inflammatory protein 1α 
MOI multiplicity of infection 
mRNA messenger RNA 
mTERT 
endogenous mouse telomerase reverse 
transcriptase 
  
N  
NaB natrium butyrate 
NELF negative elongation factor 
NFR nucleosome free region 
nm nanometer 
NURD nucleosome remodeling and histone deacetylation 
NURF nucleosome remodeling factor 
  
O  
ORF open reading frame 
  
P  
pA  polyadenylation 
PAA polyacrylamide  
PAGE polyacrylamide gel electrophoresis 
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PBS phosphate buffered saline 
PBS-T phosphate buffered saline Tween-20 
PCR  polymerase chain reaction 
PEI polyethylenimine 
PHD plant homeodomain 
PIC preinitiation complex 
Pol polymerase 
  
Q  
qPCR quantitative PCR 
  
R  
rdna DNA coding for ribosomal RNA 
RIPA radioimmunoprecipitation analysis 
RNA ribonucleic acid 
RNAPII RNA Polymerase II 
rRNA ribosomal RNA 
RT room temperature 
rtPCR Real-time PCR 
  
S  
S/MAR scaffold matrix attachment region 
SDS sodium dodecyl sulfate 
sec seconds 
Ser2P 
phosphorylation of serine 2 within the RNA 
polymerase II C-terminal domain 
Ser5P 
phosphorylation of serine 5 within the RNA 
polymerase II C-terminal domain 
SFII superfamily II 
SINE long interspersed nuclear elements 
SIN-LV self inactivating lentiviral vector 
Sp1 specificity Protein 1 
ß2-M ß2-Microglobulin 
SUV39H1 histone-lysine N-methyltransferase 
SV40  simian virus 40 
SWI/SNF switch 2/sucrose-non-fermenting 
  
T  
TF transcription factor 
TLR9 toll like receptor 
TpA thymine adenine dinucleotide 
TpC thymine cytosine dinucleotide 
TRAP thyroid hormone receptor associated protein 
tRNA transfer RNA 
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TSS transcription start site 
TTS transcription termination site 
UCOE ubiquitously chromatin opening element 
UTR untranslated region 
VCN vector copy number 
WHP woodchuck hepatitis virus  
WPRE 
woodchuck hepatitis virus (WHP) 
posttranscriptional regulatory element  
  
X  
X-Gal  5-Bromo-4-chloro-3-indolyl-ß-D-Galactopyranosid 
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 Sequences 9.2
 Murine MIP-1α variants  9.2.1
 
mmip-1α 7CpG (mMIP-wt) 
 
1  ATGAAGGTCT CCACCACTGC CCTTGCTGTT CTTCTCTGTA CCATGACACT CTGCAACCAA  
61 GTCTTCTCAG CGCCATATGG AGCTGACACC CCGACTGCCT GCTGCTTCTC CTACAGCCGG  
121 AAGATTCCAC GCCAATTCAT CGTTGACTAT TTTGAAACCA GCAGCCTTTG CTCCCAGCCA  
181 GGTGTCATTT TCCTGACTAA GAGAAACCGG CAGATCTGCG CTGACTCCAA AGAGACCTGG  
241 GTCCAAGAAT ACATCACTGA CCTGGAACTG AATGCCTAG 
 
mmip-1α 0CpG (mMIP-0) 
 
1  ATGAAGGTGA GCACAACAGC TCTGGCTGTG CTGCTGTGTA CCATGACCCT GTGCAACCAG  
61 GTGTTCTCTG CCCCTTATGG AGCAGATACC CCTACAGCCT GCTGTTTCAG CTACAGCAGG  
121 AAGATCCCCA GGCAGTTCAT TGTGGACTAC TTTGAGACCA GCAGCCTGTG TTCTCAGCCT  
181 GGGGTGATCT TTCTGACCAA GAGGAACAGG CAGATCTGTG CAGACAGCAA GGAGACATGG  
241 GTGCAGGAGT ACATCACAGA CCTGGAGCTG AATGCCTAG 
 
mmip-1α 13CpG (mMIP-13 
 
1  ATGAAGGTGA GCACCACAGC TCTGGCTGTG CTGCTGTGCA CCATGACCCT GTGCAACCAG  
61 GTGTTCAGCG CTCCTTACGG CGCCGATACC CCTACAGCCT GCTGCTTCAG CTACAGCAGG  
121 AAGATCCCCA GGCAGTTCAT CGTGGACTAC TTCGAGACCA GCAGCCTGTG TTCTCAGCCC  
181 GGCGTGATCT TCCTGACCAA GCGGAACAGA CAGATCTGCG CCGACAGCAA GGAGACATGG  
241 GTGCAGGAGT ACATCACCGA CCTGGAGCTG AACGCCTAG 
 
mmip-1α 42CpG (mMIP-42) 
 
1  ATGAAGGTGT CGACGACCGC GCTCGCCGTG CTGCTGTGCA CGATGACGCT GTGCAACCAG  
61 GTGTTCAGCG CCCCGTACGG CGCCGACACG CCGACCGCGT GCTGCTTCTC GTACTCGCGG  
121 AAGATCCCGC GGCAGTTCAT CGTCGACTAC TTCGAAACGT CGTCGCTGTG CTCGCAGCCC  
181 GGCGTGATCT TCCTCACGAA GCGGAACCGG CAGATCTGCG CCGACTCGAA GGAAACGTGG  
241 GTGCAGGAGT ACATCACCGA CCTCGAACTG AACGCGTAG 
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 Humanized GFP variants 9.2.2
 
hgfp 0CpG (hGFP-0) 
          
1  ATGGTGTCCA AGGGGGAGGA GCTGTTCACA GGGGTGGTGC CCATCCTGGT GGAGCTGGAT 
61 GGGGATGTGA ATGGCCACAA GTTCTCTGTG TCTGGGGAGG GGGAGGGGGA TGCCACCTAT 
121 GGCAAGCTCA CCCTGAAGTT CATCTGCACC ACAGGCAAGC TGCCAGTGCC CTGGCCCACC  
181 CTGGTGACCA CCTTCACCTA TGGGGTGCAG TGCTTCAGCA GATACCCAGA CCACATGAAG    
241 CAGCATGACT TCTTCAAGTC TGCCATGCCT GAGGGCTATG TGCAGGAGAG GACCATCTTC 
301 TTCAAGGATG ATGGCAACTA CAAGACCAGG GCTGAGGTGA AGTTTGAGGG GGATACCCTG 
361 GTGAACAGGA TTGAGCTGAA GGGCATTGAC TTTAAGGAGG ATGGCAATAT CCTGGGCCAC 
421 AAGCTGGAGT ACAACTACAA CAGCCACAAT GTGTACATCA TGGCAGACAA GCAGAAGAAT  
481 GGCATCAAGG TGAACTTCAA GATCAGGCAC AACATTGAGG ATGGCTCTGT GCAGCTGGCA  
541 GACCACTACC AGCAGAACAC CCCCATTGGA GATGGCCCTG TCCTGCTGCC AGACAACCAC 
601 TACCTGAGCA CCCAGTCTGC CCTGAGCAAG GACCCCAATG AGAAGAGGGA CCACATGGTG 
661 CTGCTGGAGT TTGTGACAGC TGCTGGCATC ACCCTGGGCA TGGATGAGCT GTACAAGTGA  
 
 
 
 
hgfp 60CpG (hGFP-60) 
 
1  ATGGTGAGCA AGGGCGAGGA GCTGTTCACC GGGGTGGTGC CCATCCTGGT CGAGCTGGAC  
61 GGCGACGTAA ACGGCCACAA GTTCAGCGTG TCCGGCGAGG GCGAGGGCGA TGCCACCTAC  
121 GGCAAGCTGA CCCTGAAGTT CATCTGCACC ACCGGCAAGC TGCCCGTGCC CTGGCCCACC 
181 CTCGTGACCA CCTTCACCTA CGGCGTGCAG TGCTTCAGCC GCTACCCCGA CCACATGAAG 
241 CAGCACGACT TCTTCAAGTC CGCCATGCCC GAAGGCTACG TCCAGGAGCG CACCATCTTC 
301 TTCAAGGACG ACGGCAACTA CAAGACCCGC GCCGAGGTGA AGTTCGAGGG CGACACCCTG 
361 GTGAACCGCA TCGAGCTGAA GGGCATCGAC TTCAAGGAGG ACGGCAACAT CCTGGGGCAC  
421 AAGCTGGAGT ACAACTACAA CAGCCACAAC GTCTATATCA TGGCCGACAA GCAGAAGAAC  
481 GGCATCAAGG TGAACTTCAA GATCCGCCAC AACATCGAGG ACGGCAGCGT GCAGCTCGCC 
541 GACCACTACC AGCAGAACAC CCCCATCGGC GACGGCCCCG TGCTGCTGCC CGACAACCAC 
601 TACCTGAGCA CCCAGTCCGC CCTGAGCAAA GACCCCAACG AGAAGCGCGA TCACATGGTC 
661 CTGCTGGAGT TCGTGACCGC CGCCGGGATC ACTCTCGGCA TGGACGAGCT GTACAAGTAA  
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